Glucocorticoid-induced	O
cell	O
death	O
requires	O
autoinduction	O
of	O
glucocorticoid	B-protein
receptor	I-protein
expression	O
in	O
human	B-cell_type
leukemic	I-cell_type
T	I-cell_type
cells	I-cell_type
.	O

In	O
contrast	O
to	O
the	O
negative	O
autoregulation	O
of	O
glucocorticoid	B-protein
receptor	I-protein
(	O
GR	B-protein
)	O
expression	O
seen	O
in	O
most	O
cells	O
and	O
tissues	O
,	O
GR	B-protein
expression	O
is	O
positively	O
autoregulated	O
in	O
human	B-cell_type
leukemic	I-cell_type
T	I-cell_type
cells	I-cell_type
and	O
in	O
other	O
cells	O
sensitive	O
to	O
glucocorticoid-induced	O
cell	O
death	O
.	O

To	O
determine	O
whether	O
positive	O
autoregulation	O
is	O
a	O
necessary	O
component	O
of	O
glucocorticoid-induced	O
cell	O
death	O
,	O
a	O
wild-type	B-DNA
GR	I-DNA
gene	I-DNA
under	O
the	O
control	O
of	O
a	O
tetracycline-regulated	B-DNA
promoter	I-DNA
was	O
stably	O
transfected	O
into	O
glucocorticoid-resistant	B-cell_line
cells	I-cell_line
lacking	O
endogenous	O
functional	O
receptor	O
.	O

Transfectants	B-cell_line
grown	O
in	O
the	O
presence	O
of	O
tetracycline	O
contained	O
about	O
15	O
,	O
000	O
receptors/cell	O
,	O
a	O
value	O
approximately	O
equal	O
to	O
basal	O
level	O
GR	B-protein
expression	O
in	O
glucocorticoid-sensitive	B-cell_line
6TG1.1	I-cell_line
cells	I-cell_line
before	O
steroid	O
treatment	O
.	O

Under	O
these	O
conditions	O
,	O
dexamethasone	O
had	O
a	O
minimal	O
effect	O
on	O
cell	O
growth	O
,	O
elicited	O
little	O
internucleosomal	O
DNA	O
fragmentation	O
,	O
and	O
induced	O
no	O
cell	O
cycle	O
perturbation	O
.	O

In	O
the	O
absence	O
of	O
tetracycline	O
,	O
GR	B-RNA
mRNA	I-RNA
and	O
protein	O
expression	O
increased	O
2-3-fold	O
,	O
and	O
cells	O
expressed	O
48	O
,	O
000	O
receptors	O
,	O
a	O
level	O
nearly	O
equivalent	O
to	O
that	O
present	O
in	O
6TG1.1	B-cell_line
cells	I-cell_line
after	O
18	O
h	O
of	O
autoinduction	O
.	O

Under	O
these	O
conditions	O
,	O
dexamethasone	O
markedly	O
inhibited	O
cell	O
growth	O
,	O
caused	O
G1	O
arrest	O
,	O
and	O
induced	O
significant	O
internucleosomal	O
DNA	O
fragmentation	O
.	O

These	O
studies	O
therefore	O
suggest	O
that	O
basal	O
level	O
GR	B-protein
expression	O
is	O
inadequate	O
to	O
mediate	O
glucocorticoid-induced	O
apoptosis	O
in	O
glucocorticoid-sensitive	B-cell_line
T	I-cell_line
cells	I-cell_line
and	O
that	O
positive	O
autoregulation	O
is	O
a	O
necessary	O
component	O
of	O
this	O
process	O
.	O

[	NULL
CANCER	NULL
RESEARCH	NULL
59	NULL
,	NULL
1378-1385	NULL
,	NULL
March	NULL
15	NULL
,	NULL
1999	NULL
]	NULL
Glucocorticoid-induced	NULL
Cell	NULL
Death	NULL
Requires	NULL
Autoinduction	NULL
of	NULL
Glucocorticoid	NULL
Receptor	NULL
Expression	NULL
in	NULL
Human	NULL
Leukemic	NULL
T	NULL
Cells	NULL
Jyoti	NULL
Ramdas	NULL
,	NULL
Wei	NULL
Liu	NULL
,	NULL
*	NULL
and	NULL
Jeffrey	NULL
M.	NULL
Harmon*	NULL
Department	NULL
of	NULL
Pharmacology	NULL
,	NULL
Uniformed	NULL
Services	NULL
University	NULL
of	NULL
the	NULL
Health	NULL
Sciences	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20814-4799	NULL
ABSTRACT	NULL
In	NULL
contrast	NULL
to	NULL
the	NULL
negative	NULL
autoregulation	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
(	NULL
GR	NULL
)	NULL
expression	NULL
seen	NULL
in	NULL
most	NULL
cells	NULL
and	NULL
tissues	NULL
,	NULL
GR	NULL
expression	NULL
is	NULL
positively	NULL
autoregulated	NULL
in	NULL
human	NULL
leukemic	NULL
T	NULL
cells	NULL
and	NULL
in	NULL
other	NULL
cells	NULL
sensitive	NULL
to	NULL
glucocorticoid-induced	NULL
cell	NULL
death	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
positive	NULL
autoregulation	NULL
is	NULL
a	NULL
necessary	NULL
component	NULL
of	NULL
glucocorticoid-induced	NULL
cell	NULL
death	NULL
,	NULL
a	NULL
wild-type	NULL
GR	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
a	NULL
tetracycline-regulated	NULL
promoter	NULL
was	NULL
stably	NULL
transfected	NULL
into	NULL
glucocorticoid-resistant	NULL
cells	NULL
lacking	NULL
endogenous	NULL
functional	NULL
receptor	NULL
.	NULL

Transfectants	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
tetracycline	NULL
contained	NULL
about	NULL
15,000	NULL
receptors/cell	NULL
,	NULL
a	NULL
value	NULL
approximately	NULL
equal	NULL
to	NULL
basal	NULL
level	NULL
GR	NULL
expression	NULL
in	NULL
glucocorticoid-sensitive	NULL
6TG1.1	NULL
cells	NULL
before	NULL
steroid	NULL
treatment	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
dexamethasone	NULL
had	NULL
a	NULL
minimal	NULL
effect	NULL
on	NULL
cell	NULL
growth	NULL
,	NULL
elicited	NULL
little	NULL
internucleosomal	NULL
DNA	NULL
fragmentation	NULL
,	NULL
and	NULL
induced	NULL
no	NULL
cell	NULL
cycle	NULL
perturbation	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
tetracycline	NULL
,	NULL
GR	NULL
mRNA	NULL
and	NULL
protein	NULL
expression	NULL
increased	NULL
2-3-fold	NULL
,	NULL
and	NULL
cells	NULL
expressed	NULL
48,000	NULL
receptors	NULL
,	NULL
a	NULL
level	NULL
nearly	NULL
equivalent	NULL
to	NULL
that	NULL
present	NULL
in	NULL
6TG1.1	NULL
cells	NULL
after	NULL
18	NULL
h	NULL
of	NULL
autoinduction	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
dexamethasone	NULL
markedly	NULL
inhibited	NULL
cell	NULL
growth	NULL
,	NULL
caused	NULL
G	NULL
,	NULL
arrest	NULL
,	NULL
and	NULL
induced	NULL
significant	NULL
internucleosomal	NULL
DNA	NULL
fragmentation	NULL
.	NULL

These	NULL
studies	NULL
therefore	NULL
suggest	NULL
that	NULL
basal	NULL
level	NULL
GR	NULL
expression	NULL
is	NULL
inadequate	NULL
to	NULL
mediate	NULL
glucocorticoid-induced	NULL
apoptosis	NULL
in	NULL
glucocorticoid-sensitive	NULL
T	NULL
cells	NULL
and	NULL
that	NULL
positive	NULL
autoregulation	NULL
is	NULL
a	NULL
necessary	NULL
component	NULL
of	NULL
this	NULL
process	NULL
.	NULL

INTRODUCTION	NULL
The	NULL
GR*	NULL
is	NULL
a	NULL
ubiquitously	NULL
expressed	NULL
ligand-dependent	NULL
transcription	NULL
factor	NULL
that	NULL
regulates	NULL
the	NULL
activities	NULL
of	NULL
a	NULL
large	NULL
number	NULL
of	NULL
genes	NULL
.	NULL

In	NULL
general	NULL
,	NULL
studies	NULL
that	NULL
have	NULL
examined	NULL
the	NULL
relationship	NULL
between	NULL
GR	NULL
concentration	NULL
and	NULL
biological	NULL
response	NULL
have	NULL
found	NULL
a	NULL
direct	NULL
correlation	NULL
between	NULL
GR	NULL
concentration	NULL
and	NULL
the	NULL
magnitude	NULL
of	NULL
the	NULL
response	NULL
(	NULL
1	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
the	NULL
sensitivity	NULL
of	NULL
many	NULL
lymphoid	NULL
cell	NULL
lines	NULL
to	NULL
glucocorticoid-induced	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
is	NULL
directly	NULL
related	NULL
to	NULL
intracellular	NULL
receptor	NULL
concentration	NULL
(	NULL
2-4	NULL
)	NULL
.	NULL

Bourgeois	NULL
and	NULL
Newby	NULL
(	NULL
3	NULL
)	NULL
showed	NULL
that	NULL
mouse	NULL
WEHI-7	NULL
cells	NULL
,	NULL
which	NULL
contain	NULL
two	NULL
functional	NULL
copies	NULL
of	NULL
the	NULL
GR	NULL
gene	NULL
,	NULL
are	NULL
more	NULL
sensitive	NULL
to	NULL
steroid-induced	NULL
cell	NULL
death	NULL
than	NULL
cells	NULL
that	NULL
contain	NULL
a	NULL
single	NULL
copy	NULL
.	NULL

Gehring	NULL
et	NULL
al	NULL
.	NULL

(	NULL
2	NULL
)	NULL
showed	NULL
a	NULL
direct	NULL
correlation	NULL
between	NULL
receptor	NULL
binding	NULL
activity	NULL
and	NULL
steroid-induced	NULL
growth	NULL
inhibition	NULL
of	NULL
different	NULL
clones	NULL
of	NULL
$	NULL
49	NULL
cells	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
Chapman	NULL
et	NULL
al	NULL
.	NULL

(	NULL
4	NULL
)	NULL
demonstrated	NULL
a	NULL
correlation	NULL
between	NULL
steroid	NULL
sensitivity	NULL
and	NULL
the	NULL
level	NULL
of	NULL
GR	NULL
expression	NULL
in	NULL
different	NULL
clones	NULL
of	NULL
receptor-less	NULL
$	NULL
49	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
mouse	NULL
GR	NULL
gene	NULL
.	NULL

However	NULL
,	NULL
the	NULL
minimum	NULL
concentration	NULL
of	NULL
GR	NULL
necessary	NULL
to	NULL
mediate	NULL
an	NULL
apoptotic	NULL
response	NULL
has	NULL
not	NULL
been	NULL
established	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
although	NULL
there	NULL
is	NULL
a	NULL
Received	NULL
11/2/98	NULL
;	NULL
accepted	NULL
1/21/99	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

Supported	NULL
by	NULL
USPHS	NULL
Grant	NULL
CA32226	NULL
awarded	NULL
by	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
to	NULL
J.	NULL
M.	NULL
H.	NULL
The	NULL
opinions	NULL
or	NULL
assertions	NULL
contained	NULL
herein	NULL
are	NULL
the	NULL
private	NULL
ones	NULL
of	NULL
the	NULL
authors	NULL
and	NULL
are	NULL
not	NULL
to	NULL
be	NULL
construed	NULL
as	NULL
official	NULL
or	NULL
reflecting	NULL
the	NULL
views	NULL
of	NULL
the	NULL
Department	NULL
of	NULL
Defense	NULL
or	NULL
the	NULL
Uniformed	NULL
Services	NULL
University	NULL
of	NULL
the	NULL
Health	NULL
Sciences	NULL
.	NULL

>	NULL
Present	NULL
address	NULL
:	NULL
Laboratory	NULL
of	NULL
Cellular	NULL
Biology	NULL
,	NULL
National	NULL
Institute	NULL
on	NULL
Deafness	NULL
and	NULL
Other	NULL
Communication	NULL
Disorders	NULL
,	NULL
NIH	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20850	NULL
.	NULL

>	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
,	NULL
at	NULL
Department	NULL
of	NULL
Pharmacology	NULL
,	NULL
Uniformed	NULL
Services	NULL
University	NULL
of	NULL
the	NULL
Health	NULL
Sciences	NULL
,	NULL
4301	NULL
Jones	NULL
Bridge	NULL
Road	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20814-4799	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
301	NULL
)	NULL
295-3248	NULL
;	NULL
Fax	NULL
:	NULL
(	NULL
301	NULL
)	NULL
295-3220	NULL
;	NULL
E-mail	NULL
:	NULL
jharmon	NULL
@	NULL
usuhs.mil	NULL
.	NULL

*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
GR	NULL
,	NULL
glucocorticoid	NULL
receptor	NULL
;	NULL
hGR	NULL
,	NULL
human	NULL
GR	NULL
;	NULL
HA	NULL
,	NULL
influenza	NULL
hemagglutinin	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
RT-PCR	NULL
,	NULL
reverse	NULL
transcription-PCR	NULL
.	NULL

strong	NULL
correlation	NULL
between	NULL
GR	NULL
concentration	NULL
and	NULL
steroid	NULL
sensitivity	NULL
when	NULL
clonal	NULL
cell	NULL
lines	NULL
are	NULL
compared	NULL
,	NULL
studies	NULL
that	NULL
have	NULL
attempted	NULL
to	NULL
correlate	NULL
GR	NULL
concentration	NULL
with	NULL
therapeutic	NULL
response	NULL
in	NULL
the	NULL
treatment	NULL
of	NULL
leukemias	NULL
and	NULL
lymphomas	NULL
have	NULL
proven	NULL
contradictory	NULL
(	NULL
5-11	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
additional	NULL
factors	NULL
must	NULL
contribute	NULL
to	NULL
determining	NULL
the	NULL
sensitivity	NULL
of	NULL
lymphoid	NULL
cells	NULL
to	NULL
steroid-induced	NULL
lymphocytolysis	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
negative	NULL
autoregulation	NULL
of	NULL
GR	NULL
expression	NULL
seen	NULL
in	NULL
most	NULL
cells	NULL
and	NULL
tissues	NULL
,	NULL
the	NULL
hGR	NULL
is	NULL
positively	NULL
autoregulated	NULL
in	NULL
glucocorticoid-sensitive	NULL
human	NULL
leukemic	NULL
6TG1.1	NULL
cells	NULL
(	NULL
12	NULL
)	NULL
.	NULL

In	NULL
response	NULL
to	NULL
glucocorticoid	NULL
treatment	NULL
,	NULL
hGR	NULL
mRNA	NULL
and	NULL
protein	NULL
increase	NULL
several-fold	NULL
during	NULL
the	NULL
first	NULL
24	NULL
h	NULL
of	NULL
steroid	NULL
treatment	NULL
.	NULL

These	NULL
increases	NULL
appear	NULL
to	NULL
be	NULL
the	NULL
result	NULL
of	NULL
increased	NULL
transcription	NULL
of	NULL
the	NULL
hGR	NULL
gene	NULL
and	NULL
precede	NULL
the	NULL
earliest	NULL
evidence	NULL
of	NULL
glucocorticoid-induced	NULL
growth	NULL
arrest	NULL
and	NULL
cell	NULL
death	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Positive	NULL
autoregulation	NULL
of	NULL
GR	NULL
expression	NULL
has	NULL
also	NULL
been	NULL
confirmed	NULL
in	NULL
other	NULL
clonal	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
human	NULL
leukemic	NULL
CEM	NULL
cells	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
as	NULL
well	NULL
as	NULL
glucocorticoid-sensitive	NULL
mouse	NULL
$	NULL
49	NULL
cells	NULL
(	NULL
16	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
of	NULL
two	NULL
human	NULL
myeloma	NULL
cell	NULL
lines	NULL
established	NULL
from	NULL
the	NULL
same	NULL
patient	NULL
,	NULL
the	NULL
hGR	NULL
was	NULL
positively	NULL
autoregulated	NULL
in	NULL
the	NULL
cell	NULL
line	NULL
that	NULL
was	NULL
glucocorticoid	NULL
sensitive	NULL
,	NULL
but	NULL
not	NULL
in	NULL
the	NULL
one	NULL
that	NULL
was	NULL
glucocorticoid	NULL
resistant	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
positive	NULL
autoregulation	NULL
of	NULL
GR	NULL
expression	NULL
may	NULL
be	NULL
a	NULL
necessary	NULL
component	NULL
of	NULL
glucocorticoid-induced	NULL
growth	NULL
arrest	NULL
and	NULL
cell	NULL
death	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
positive	NULL
autoregulation	NULL
of	NULL
hGR	NULL
expression	NULL
in	NULL
steroid-induced	NULL
growth	NULL
arrest	NULL
and	NULL
cell	NULL
death	NULL
,	NULL
we	NULL
have	NULL
introduced	NULL
a	NULL
functional	NULL
copy	NULL
of	NULL
the	NULL
hGR	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
a	NULL
tetracycline-regulated	NULL
promoter	NULL
into	NULL
glucocorticoid-resistant	NULL
ICR27TK.3	NULL
cells	NULL
.	NULL

ICR27TK.3	NULL
cells	NULL
are	NULL
AGR/GR753F	NULL
and	NULL
were	NULL
derived	NULL
from	NULL
the	NULL
glucocorticoid-sensitive	NULL
cell	NULL
line	NULL
6TG1.1	NULL
,	NULL
whose	NULL
genotype	NULL
is	NULL
GR*/	NULL
GR753F	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
mutant	NULL
hGR	NULL
present	NULL
in	NULL
these	NULL
cells	NULL
is	NULL
activation	NULL
deficient	NULL
;	NULL
although	NULL
it	NULL
can	NULL
repress	NULL
activator	NULL
protein	NULL
1	NULL
activity	NULL
,	NULL
it	NULL
can	NULL
not	NULL
induce	NULL
transcription	NULL
from	NULL
the	NULL
mouse	NULL
mammary	NULL
tumor	NULL
virus	NULL
promoter	NULL
or	NULL
mediate	NULL
steroid-induced	NULL
growth	NULL
arrest	NULL
or	NULL
cell	NULL
death	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Using	NULL
a	NULL
stably	NULL
transfected	NULL
cell	NULL
line	NULL
that	NULL
expresses	NULL
a	NULL
functional	NULL
hGR	NULL
gene	NULL
whose	NULL
expression	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
concentration	NULL
of	NULL
tetracycline	NULL
in	NULL
the	NULL
growth	NULL
medium	NULL
,	NULL
we	NULL
show	NULL
that	NULL
steroid	NULL
treatment	NULL
of	NULL
transfected	NULL
cells	NULL
that	NULL
express	NULL
a	NULL
concentration	NULL
of	NULL
GR	NULL
equivalent	NULL
to	NULL
that	NULL
present	NULL
in	NULL
6TG1.1	NULL
cells	NULL
before	NULL
steroid	NULL
treatment	NULL
elicits	NULL
only	NULL
a	NULL
small	NULL
decrease	NULL
in	NULL
cell	NULL
growth	NULL
and	NULL
induces	NULL
little	NULL
cell	NULL
death	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
steroid	NULL
treatment	NULL
of	NULL
transfected	NULL
cells	NULL
that	NULL
express	NULL
a	NULL
concentration	NULL
of	NULL
GR	NULL
more	NULL
equal	NULL
to	NULL
that	NULL
seen	NULL
in	NULL
6TG1.1	NULL
cells	NULL
18-24	NULL
h	NULL
after	NULL
steroid	NULL
treatment	NULL
results	NULL
in	NULL
increased	NULL
growth	NULL
arrest	NULL
and	NULL
substantial	NULL
apoptosis	NULL
,	NULL
suggesting	NULL
that	NULL
basal	NULL
levels	NULL
of	NULL
hGR	NULL
expression	NULL
are	NULL
inadequate	NULL
to	NULL
mediate	NULL
an	NULL
apoptotic	NULL
response	NULL
and	NULL
that	NULL
positive	NULL
autoregulation	NULL
of	NULL
hGR	NULL
expression	NULL
may	NULL
provide	NULL
a	NULL
mechanism	NULL
to	NULL
amplify	NULL
the	NULL
hormonal	NULL
signal	NULL
in	NULL
cells	NULL
programmed	NULL
to	NULL
die	NULL
in	NULL
response	NULL
to	NULL
steroid	NULL
treatment	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmids	NULL
.	NULL

Plasmid	NULL
pZeoSV	NULL
was	NULL
obtained	NULL
from	NULL
Invitrogen	NULL
(	NULL
Carlsbad	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

pZeo	NULL
was	NULL
constructed	NULL
by	NULL
removing	NULL
the	NULL
622-bp	NULL
BamHI/Clel	NULL
fragment	NULL
of	NULL
pZeoSV	NULL
containing	NULL
the	NULL
SV40	NULL
promoter	NULL
and	NULL
polyA	NULL
addition	NULL
signal	NULL
sequence	NULL
and	NULL
replacing	NULL
it	NULL
with	NULL
a	NULL
linker	NULL
sequence	NULL
containing	NULL
Xhkol	NULL
and	NULL
Pvull	NULL
sites	NULL
.	NULL

Plasmids	NULL
pUHD10-3	NULL
and	NULL
pUHD15-1	NULL
neo	NULL
were	NULL
generous	NULL
gifts	NULL
of	NULL
Drs	NULL
.	NULL

Hermann	NULL
Bujard	NULL
(	NULL
Zentrum	NULL
fiir	NULL
Molekulare	NULL
Biolgie	NULL
der	NULL
Universitit	NULL
Heidelberg	NULL
,	NULL
Heidelberg	NULL
,	NULL
Germany	NULL
)	NULL
and	NULL
Steven	NULL
Reed	NULL
(	NULL
Scripps	NULL
Research	NULL
Institue	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
(	NULL
21	NULL
,	NULL
1378	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1999	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

GR	NULL
AUTOREGULATION	NULL
AND	NULL
STEROID-INDUCED	NULL
CELL	NULL
DEATH	NULL
22	NULL
)	NULL
.	NULL

pRShGRHA17	NULL
containing	NULL
three	NULL
repeats	NULL
of	NULL
the	NULL
HA	NULL
epitope	NULL
was	NULL
constructed	NULL
by	NULL
subcloning	NULL
the	NULL
1-kb	NULL
Sa/l/Clel	NULL
fragment	NULL
of	NULL
pRShGRe	NULL
(	NULL
23	NULL
)	NULL
containing	NULL
the	NULL
region	NULL
of	NULL
the	NULL
NH	NULL
,	NULL
-terminal	NULL
domain	NULL
of	NULL
the	NULL
hGR	NULL
(	NULL
C245	NULL
to	NULL
T272	NULL
)	NULL
against	NULL
which	NULL
the	NULL
antipeptide	NULL
anti-GR	NULL
antibody	NULL
710	NULL
was	NULL
raised	NULL
(	NULL
18	NULL
)	NULL
into	NULL
Sall/Clal-digested	NULL
pBluescript	NULL
SK+	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Unique	NULL
Xbal	NULL
and	NULL
SacI	NULL
sites	NULL
flanking	NULL
the	NULL
immunogenic	NULL
sequence	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
internal	NULL
467-bp	NULL
Styl	NULL
fragment	NULL
by	NULL
PCR	NULL
amplification	NULL
with	NULL
mutant	NULL
oligonu-cleotides	NULL
,	NULL
and	NULL
the	NULL
1-kb	NULL
SeZl/Clel	NULL
fragment	NULL
of	NULL
the	NULL
resulting	NULL
plasmid	NULL
was	NULL
used	NULL
to	NULL
replace	NULL
the	NULL
corresponding	NULL
fragment	NULL
of	NULL
pRShGRa	NULL
to	NULL
create	NULL
pGRM	NULL
.	NULL

Four	NULL
overlapping	NULL
,	NULL
complimentary	NULL
synthetic	NULL
oligonucleotides	NULL
(	NULL
5'-TTCCTT-CTAGAAGGAAACTCGAATGAGGACTACCCATACGACGTCCCAGAC-	NULL
5'-ACTACCCATACGACGTCCCAGACTACGCTTAC-CCATACGACGTCCCAGACTACGCTTACCCATACGACGTCCCA-	NULL
5-GACGTCCCAGACTACGCTA-CACTGCCCCAAGTGAAAACAGAAAAAGAAGATTTCATCGAG-	NULL
and	NULL
5'-AGGGGTGCAGAGCTCGATGAAATCTTC-3	NULL
'	NULL
)	NULL
encoding	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
HA	NULL
epitope	NULL
(	NULL
YPYDVPDYA	NULL
)	NULL
were	NULL
annealed	NULL
;	NULL
after	NULL
filling	NULL
the	NULL
gaps	NULL
with	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
Poll	NULL
and	NULL
digestion	NULL
with	NULL
Xbal	NULL
and	NULL
SacI	NULL
,	NULL
they	NULL
were	NULL
used	NULL
to	NULL
replace	NULL
the	NULL
149-bp	NULL
Xbal/SacI	NULL
fragment	NULL
of	NULL
pGRM	NULL
to	NULL
create	NULL
the	NULL
hGR	NULL
expression	NULL
plasmid	NULL
pRShGRHA17	NULL
.	NULL

The	NULL
GR	NULL
protein	NULL
containing	NULL
the	NULL
HA	NULL
epitope	NULL
was	NULL
fully	NULL
active	NULL
in	NULL
the	NULL
ligand-dependent	NULL
induction	NULL
of	NULL
pMSG-CAT	NULL
and	NULL
the	NULL
repression	NULL
of	NULL
-73	NULL
COL-CAT	NULL
when	NULL
transfected	NULL
into	NULL
COS-7	NULL
cells	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
19	NULL
)	NULL
.	NULL

ptetGRa	NULL
:	NULL
was	NULL
constructed	NULL
by	NULL
amplification	NULL
of	NULL
the	NULL
entire	NULL
coding	NULL
region	NULL
of	NULL
the	NULL
GR	NULL
gene	NULL
from	NULL
pRShGRa	NULL
with	NULL
forward	NULL
primer	NULL
5'-ACAACACCGCGGATATTCACTGATG-GACTCC-3	NULL
'	NULL
and	NULL
reverse	NULL
primer	NULL
GATCTACAACA-3	NULL
'	NULL
,	NULL
digestion	NULL
with	NULL
Secll	NULL
and	NULL
Xbal	NULL
,	NULL
and	NULL
insertion	NULL
into	NULL
Sacll/	NULL
Xbal-digested	NULL
pUHD10-3	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
GR	NULL
gene	NULL
was	NULL
confirmed	NULL
by	NULL
complete	NULL
double-strand	NULL
sequencing	NULL
.	NULL

Transient	NULL
cotransfection	NULL
of	NULL
pUHD15-1	NULL
neo	NULL
,	NULL
ptetGRa	NULL
,	NULL
and	NULL
pMSG-CAT	NULL
into	NULL
CV-1	NULL
cells	NULL
confirmed	NULL
that	NULL
the	NULL
GR	NULL
gene	NULL
in	NULL
ptetGR	NULL
was	NULL
functional	NULL
and	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
fefO	NULL
sequence	NULL
;	NULL
growth	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
pg/ml	NULL
tetracycline	NULL
repressed	NULL
chloramphenicol	NULL
acetyltrans-ferase	NULL
activity	NULL
by	NULL
>	NULL
50	NULL
%	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
pZeotetGRHA	NULL
was	NULL
constructed	NULL
by	NULL
replacing	NULL
the	NULL
1-kb	NULL
SaHl/Clel	NULL
fragment	NULL
of	NULL
ptetGRa	NULL
:	NULL
with	NULL
the	NULL
corresponding	NULL
fragment	NULL
of	NULL
pRShGRHA17	NULL
and	NULL
inserting	NULL
the	NULL
3456-bp	NULL
Xhol/Pvull	NULL
fragment	NULL
of	NULL
the	NULL
resulting	NULL
plasmid	NULL
into	NULL
Xhol/Pvull-digested	NULL
pZeo	NULL
.	NULL

Cell	NULL
Culture	NULL
and	NULL
Transfection	NULL
.	NULL

The	NULL
glucocorticoid-sensitive	NULL
T-cell	NULL
line	NULL
6GTG1.1	NULL
and	NULL
its	NULL
glucocorticoid-resistant	NULL
derivative	NULL
,	NULL
ICR27TK.3	NULL
,	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
grown	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
containing	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
;	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
human	NULL
B-cell	NULL
line	NULL
IM-9	NULL
was	NULL
grown	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
.	NULL

Cell	NULL
number	NULL
was	NULL
determined	NULL
with	NULL
a	NULL
Coulter	NULL
Counter	NULL
(	NULL
model	NULL
ZM	NULL
;	NULL
Coulter	NULL
Electronics	NULL
,	NULL
Inc.	NULL
,	NULL
Hialeah	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

For	NULL
stable	NULL
and	NULL
transient	NULL
transfections	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
during	NULL
log-phase	NULL
growth	NULL
by	NULL
centrifugation	NULL
at	NULL
200	NULL
X	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
and	NULL
resuspended	NULL
in	NULL
ice-cold	NULL
electroporation	NULL
medium	NULL
(	NULL
RPMI	NULL
1640	NULL
)	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
8	NULL
X	NULL
10°	NULL
cells/ml	NULL
.	NULL

Five	NULL
million	NULL
cells	NULL
(	NULL
0.7	NULL
ml	NULL
)	NULL
were	NULL
transferred	NULL
to	NULL
a	NULL
precooled	NULL
electroporation	NULL
cuvette	NULL
(	NULL
4-cm	NULL
gap	NULL
;	NULL
Bio-Rad	NULL
Laboratories	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
to	NULL
which	NULL
10	NULL
ug	NULL
of	NULL
linearized	NULL
plasmid	NULL
were	NULL
added	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
electroporation	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
Bio-Rad	NULL
Genepulser	NULL
apparatus	NULL
(	NULL
with	NULL
capacitance	NULL
extender	NULL
)	NULL
at	NULL
340	NULL
V	NULL
and	NULL
960	NULL
F.	NULL
Electroporated	NULL
cells	NULL
were	NULL
incubated	NULL
at	NULL
4°C	NULL
for	NULL
10	NULL
min	NULL
and	NULL
then	NULL
transferred	NULL
to	NULL
10	NULL
ml	NULL
of	NULL
culture	NULL
medium	NULL
composed	NULL
of	NULL
a	NULL
1:1	NULL
mixture	NULL
of	NULL
fresh	NULL
and	NULL
conditioned	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
JRH	NULL
Biosciences	NULL
,	NULL
Lenexa	NULL
,	NULL
KS	NULL
)	NULL
preequilibrated	NULL
for	NULL
24	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
containing	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
allowed	NULL
to	NULL
recover	NULL
for	NULL
24	NULL
h	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
mg/ml	NULL
Geneticin	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
and	NULL
the	NULL
selection	NULL
of	NULL
resistant	NULL
clones	NULL
by	NULL
limiting	NULL
dilution	NULL
in	NULL
96-well	NULL
microtiter	NULL
plates	NULL
at	NULL
1000	NULL
cells/well	NULL
.	NULL

Alternatively	NULL
,	NULL
when	NULL
cells	NULL
were	NULL
selected	NULL
for	NULL
zeocin	NULL
resistance	NULL
,	NULL
they	NULL
were	NULL
plated	NULL
in	NULL
250	NULL
pg/ml	NULL
zeocin	NULL
(	NULL
Invitro-gen	NULL
)	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
0.2	NULL
cells/ml	NULL
.	NULL

EMSA	NULL
.	NULL

A	NULL
42-bp	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
19-bp	NULL
inverted	NULL
repeat	NULL
sequence	NULL
of	NULL
the	NULL
fefO	NULL
gene	NULL
was	NULL
constructed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
and	NULL
labeled	NULL
with	NULL
[	NULL
y-*°P	NULL
]	NULL
dATP	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
and	NULL
DNA	NULL
binding	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
.	NULL

RT-PCR	NULL
.	NULL

Total	NULL
cell	NULL
RNA	NULL
was	NULL
purified	NULL
using	NULL
RNAzol	NULL
(	NULL
Tel-Test	NULL
,	NULL
Friend-swood	NULL
,	NULL
TX	NULL
)	NULL
according	NULL
to	NULL
the	NULL
directions	NULL
of	NULL
the	NULL
manufacturer	NULL
.	NULL

RT-PCR	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
Gene-Amp	NULL
RNA	NULL
PCR	NULL
Kit	NULL
(	NULL
Perkin-Elmer	NULL
Corp.	NULL
,	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

First-strand	NULL
synthesis	NULL
was	NULL
performed	NULL
in	NULL
20	NULL
gl	NULL
of	NULL
10	NULL
mm	NULL
Tris-HCl	NULL
buffer	NULL
(	NULL
pH	NULL
8.3	NULL
)	NULL
containing	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
50	NULL
mm	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
of	NULL
each	NULL
de-oxynucleotide	NULL
triphosphate	NULL
,	NULL
2.5	NULL
uM	NULL
random	NULL
hexamers	NULL
,	NULL
1	NULL
unit	NULL
of	NULL
RNase	NULL
inhib-itor	NULL
,	NULL
2.5	NULL
units	NULL
of	NULL
murine	NULL
leukemia	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
,	NULL
and	NULL
1	NULL
pg	NULL
of	NULL
total	NULL
RNA	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
10	NULL
min	NULL
,	NULL
at	NULL
42°C	NULL
for	NULL
15	NULL
min	NULL
,	NULL
at	NULL
99°C	NULL
for	NULL
5	NULL
min	NULL
,	NULL
and	NULL
at	NULL
5°C	NULL
for	NULL
5	NULL
min	NULL
in	NULL
a	NULL
Perkin-Elmer	NULL
Thermal	NULL
Cycler	NULL
model	NULL
480	NULL
.	NULL

Amplification	NULL
was	NULL
performed	NULL
by	NULL
adding	NULL
MgCl	NULL
;	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
2	NULL
mM	NULL
and	NULL
adding	NULL
sufficient	NULL
buffer	NULL
to	NULL
maintain	NULL
a	NULL
concentration	NULL
of	NULL
50	NULL
mM	NULL
KCI	NULL
.	NULL

Primers	NULL
A	NULL
(	NULL
5-TCGAATGAGGACTACCCATACGAC-3	NULL
``	NULL
)	NULL
,	NULL
B	NULL
(	NULL
5	NULL
-TCCAGGAAAGCTTGCCTGACAGTA-3	NULL
``	NULL
)	NULL
,	NULL
and	NULL
C	NULL
(	NULL
5-ATGGAGATCT-GGTTTTGTCAAGCCC-3	NULL
'	NULL
)	NULL
were	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.15	NULL
uM	NULL
,	NULL
and	NULL
AmpliTaq	NULL
DNA	NULL
Polymerase	NULL
(	NULL
2.5	NULL
units	NULL
;	NULL
Perkin-Elmer	NULL
Corp.	NULL
)	NULL
was	NULL
added	NULL
to	NULL
initiate	NULL
the	NULL
reaction	NULL
.	NULL

After	NULL
denaturation	NULL
at	NULL
95°C	NULL
for	NULL
3	NULL
min	NULL
and	NULL
30	NULL
s	NULL
,	NULL
amplification	NULL
was	NULL
accomplished	NULL
by	NULL
35	NULL
cycles	NULL
of	NULL
incubation	NULL
at	NULL
95°C	NULL
for	NULL
30	NULL
s	NULL
,	NULL
55°C	NULL
for	NULL
30	NULL
s	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
final	NULL
extension	NULL
at	NULL
72°C	NULL
for	NULL
7	NULL
min	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
purified	NULL
using	NULL
the	NULL
QIAquick-spin	NULL
column	NULL
(	NULL
Qiagen	NULL
,	NULL
Valencia	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
200	NULL
ng	NULL
of	NULL
each	NULL
product	NULL
were	NULL
electrophoresed	NULL
at	NULL
6	NULL
V/cm	NULL
in	NULL
a	NULL
1.5	NULL
%	NULL
agarose	NULL
gel	NULL
in	NULL
1	NULL
X	NULL
Tris-borate	NULL
EDTA	NULL
containing	NULL
0.5	NULL
ug/ml	NULL
!	NULL

ethidium	NULL
bromide	NULL
.	NULL

To	NULL
quantify	NULL
the	NULL
amount	NULL
of	NULL
PCR	NULL
product	NULL
,	NULL
DNA	NULL
was	NULL
visualized	NULL
with	NULL
a	NULL
UV	NULL
transilluminator	NULL
and	NULL
photographed	NULL
using	NULL
Polaroid	NULL
type	NULL
55	NULL
film	NULL
.	NULL

Negatives	NULL
were	NULL
scanned	NULL
with	NULL
a	NULL
LKB	NULL
Ultrascan	NULL
laser	NULL
densitometer	NULL
.	NULL

Analysis	NULL
of	NULL
hGR	NULL
Protein	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
[	NULL
*H	NULL
}	NULL
dexamethasone	NULL
to	NULL
intact	NULL
cells	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

For	NULL
immunoblotting	NULL
,	NULL
total	NULL
cell	NULL
protein	NULL
was	NULL
extracted	NULL
and	NULL
solubilized	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Protein	NULL
(	NULL
50	NULL
ug	NULL
)	NULL
was	NULL
electrophoresed	NULL
in	NULL
an	NULL
8	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
0.45	NULL
um	NULL
Protran	NULL
nitrocellulose	NULL
membrane	NULL
(	NULL
Schleicher	NULL
and	NULL
Schuell	NULL
,	NULL
Keene	NULL
,	NULL
NH	NULL
)	NULL
,	NULL
and	NULL
the	NULL
filter	NULL
was	NULL
incubated	NULL
overnight	NULL
at	NULL
4°C	NULL
in	NULL
TTBS	NULL
buffer	NULL
[	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
]	NULL
(	NULL
pH	NULL
7.6	NULL
)	NULL
containing	NULL
137	NULL
mM	NULL
NaCl	NULL
and	NULL
0.1	NULL
%	NULL
Tween-20	NULL
]	NULL
containing	NULL
5	NULL
%	NULL
nonfat	NULL
milk	NULL
.	NULL

The	NULL
filter	NULL
was	NULL
washed	NULL
twice	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
in	NULL
300	NULL
ml	NULL
of	NULL
TTBS	NULL
,	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
TTBS	NULL
containing	NULL
a	NULL
1:1000	NULL
dilution	NULL
of	NULL
anti-hGR	NULL
antibody	NULL
710	NULL
(	NULL
18	NULL
)	NULL
or	NULL
anti-HA	NULL
epitope	NULL
antibody	NULL
HA.11	NULL
(	NULL
Berkeley	NULL
Antibody	NULL
Co.	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
300	NULL
ml	NULL
of	NULL
TTBS	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
in	NULL
TTBS	NULL
containing	NULL
a	NULL
1:2000	NULL
dilution	NULL
of	NULL
donkey	NULL
antirabbit	NULL
IgG	NULL
conjugated	NULL
to	NULL
horseradish	NULL
peroxidase	NULL
.	NULL

Filters	NULL
were	NULL
incubated	NULL
with	NULL
equal	NULL
portions	NULL
of	NULL
luminol	NULL
and	NULL
hydrogen	NULL
peroxide	NULL
for	NULL
1	NULL
min	NULL
,	NULL
followed	NULL
by	NULL
exposure	NULL
to	NULL
Hyperfilm	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

For	NULL
quantification	NULL
of	NULL
chemiluminescence	NULL
,	NULL
filters	NULL
were	NULL
processed	NULL
using	NULL
a	NULL
Bio-Rad	NULL
Model	NULL
GS-250	NULL
Molecular	NULL
Imager	NULL
and	NULL
Molecular	NULL
Analyst	NULL
software	NULL
.	NULL

Flow	NULL
Cytometry	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
by	NULL
centrifugation	NULL
at	NULL
200	NULL
X	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
fixed	NULL
for	NULL
flow	NULL
cytometric	NULL
analysis	NULL
by	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
procedure	NULL
of	NULL
Gorezyca	NULL
et	NULL
al	NULL
.	NULL

(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
ice-cold	NULL
PBS	NULL
by	NULL
gentle	NULL
tapping	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
1.5-ml	NULL
microfuge	NULL
tube	NULL
.	NULL

After	NULL
centrifugation	NULL
at	NULL
320	NULL
X	NULL
g	NULL
for	NULL
2	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
the	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
PBS	NULL
containing	NULL
2	NULL
%	NULL
paraformaldehyde	NULL
and	NULL
incubated	NULL
at	NULL
4°C	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Fixed	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
cold	NULL
PBS	NULL
,	NULL
resuspended	NULL
in	NULL
70	NULL
%	NULL
ethanol	NULL
,	NULL
and	NULL
stored	NULL
overnight	NULL
at	NULL
-20°C	NULL
.	NULL

After	NULL
two	NULL
washes	NULL
with	NULL
cold	NULL
PBS	NULL
,	NULL
the	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
PBS	NULL
containing	NULL
200	NULL
pg/ml	NULL
RNase	NULL
A	NULL
,	NULL
50	NULL
pg/ml	NULL
propidium	NULL
iodide	NULL
,	NULL
and	NULL
0.6	NULL
%	NULL
NP4O	NULL
and	NULL
stored	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

Flow	NULL
cytometry	NULL
was	NULL
performed	NULL
using	NULL
an	NULL
Epics	NULL
Elite	NULL
Flow	NULL
Cytometer	NULL
(	NULL
Coulter	NULL
Electronics	NULL
Inc.	NULL
)	NULL
.	NULL

Data	NULL
were	NULL
collected	NULL
using	NULL
the	NULL
Elite	NULL
program	NULL
and	NULL
analyzed	NULL
using	NULL
Multi-cycle	NULL
AV	NULL
(	NULL
Phoenix	NULL
Flow	NULL
Systems	NULL
,	NULL
Inc.	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

RESULTS	NULL
Hormone-independent	NULL
Regulation	NULL
of	NULL
hGR	NULL
Expression	NULL
.	NULL

In	NULL
glucocorticoid-sensitive	NULL
CEM	NULL
cells	NULL
,	NULL
there	NULL
is	NULL
a	NULL
hormone-dependent	NULL
increase	NULL
in	NULL
both	NULL
hGR	NULL
mRNA	NULL
and	NULL
protein	NULL
before	NULL
the	NULL
onset	NULL
of	NULL
growth	NULL
arrest	NULL
and	NULL
cell	NULL
death	NULL
when	NULL
cells	NULL
are	NULL
exposed	NULL
to	NULL
steroid	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
role	NULL
of	NULL
autoregulation	NULL
of	NULL
hGR	NULL
expression	NULL
on	NULL
glucocorticoid-induced	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
of	NULL
cultured	NULL
T	NULL
cells	NULL
,	NULL
a	NULL
cell	NULL
line	NULL
was	NULL
constructed	NULL
in	NULL
which	NULL
the	NULL
concentration	NULL
of	NULL
the	NULL
receptor	NULL
could	NULL
be	NULL
regulated	NULL
in	NULL
a	NULL
hormone-independent	NULL
manner	NULL
.	NULL

Accordingly	NULL
,	NULL
the	NULL
tetracycline-inducible	NULL
expression	NULL
system	NULL
of	NULL
Gossen	NULL
and	NULL
Bujard	NULL
(	NULL
21	NULL
)	NULL
was	NULL
used	NULL
to	NULL
express	NULL
HA-tagged	NULL
hGR	NULL
in	NULL
glucocorticoid-resistant	NULL
ICR27TK.3	NULL
cells	NULL
.	NULL

The	NULL
resistance	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
steroid-induced	NULL
cell	NULL
death	NULL
is	NULL
the	NULL
consequence	NULL
of	NULL
a	NULL
deletion	NULL
of	NULL
one	NULL
hGR	NULL
gene	NULL
and	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
other	NULL
(	NULL
L753F	NULL
)	NULL
that	NULL
renders	NULL
it	NULL
activation-deficient	NULL
and	NULL
unable	NULL
to	NULL
mediate	NULL
glucocorticoid-induced	NULL
growth	NULL
arrest	NULL
or	NULL
cell	NULL
death	NULL
1379	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1999	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

GR	NULL
AUTOREGULATION	NULL
AND	NULL
STEROID-INDUCED	NULL
CELL	NULL
DEATH	NULL
(	NULL
Refs	NULL
.	NULL

18	NULL
and	NULL
26	NULL
;	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Plasmid	NULL
pUHD15-1	NULL
neo	NULL
,	NULL
which	NULL
expresses	NULL
the	NULL
chimeric	NULL
tTA	NULL
transactivator	NULL
protein	NULL
,	NULL
was	NULL
transfected	NULL
into	NULL
ICR27TK.3	NULL
cells	NULL
,	NULL
and	NULL
neomycin-resistant	NULL
clones	NULL
were	NULL
screened	NULL
for	NULL
tTA	NULL
expression	NULL
by	NULL
EMSA	NULL
using	NULL
the	NULL
tetO	NULL
sequence	NULL
as	NULL
a	NULL
probe	NULL
and	NULL
by	NULL
assaying	NULL
B-galactosidase	NULL
activity	NULL
in	NULL
cells	NULL
that	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
tetracycline-responsive	NULL
reporter	NULL
plasmid	NULL
pUHC16-3	NULL
.	NULL

Cells	NULL
that	NULL
expressed	NULL
the	NULL
highest	NULL
level	NULL
of	NULL
tTA	NULL
(	NULL
as	NULL
measured	NULL
by	NULL
EMSA	NULL
)	NULL
and	NULL
in	NULL
which	NULL
B-galactosidase	NULL
expression	NULL
from	NULL
a	NULL
transiently	NULL
transfected	NULL
tTA-regulated	NULL
,	NULL
reporter	NULL
plasmid	NULL
was	NULL
repressed	NULL
by	NULL
growth	NULL
in	NULL
medium	NULL
containing	NULL
tetracycline	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
were	NULL
then	NULL
transfected	NULL
with	NULL
plasmid	NULL
pZeotetGRaHA17	NULL
that	NULL
expresses	NULL
the	NULL
HA-tagged	NULL
GR	NULL
downstream	NULL
of	NULL
a	NULL
heptameric	NULL
repeat	NULL
of	NULL
the	NULL
fetO	NULL
sequence	NULL
and	NULL
a	NULL
minimal	NULL
eukaryotic	NULL
promoter	NULL
(	NULL
phCMV'-1	NULL
)	NULL
and	NULL
also	NULL
contains	NULL
a	NULL
gene	NULL
conferring	NULL
resistance	NULL
to	NULL
zeocin	NULL
.	NULL

Cells	NULL
resistant	NULL
to	NULL
both	NULL
Geneticin	NULL
and	NULL
zeocin	NULL
were	NULL
assayed	NULL
for	NULL
dexamethasone-induced	NULL
growth	NULL
inhibition	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
tetracycline	NULL
.	NULL

The	NULL
majority	NULL
of	NULL
drug-resistant	NULL
clones	NULL
showed	NULL
greater	NULL
steroid-induced	NULL
growth	NULL
inhibition	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
tetracycline	NULL
.	NULL

Several	NULL
of	NULL
these	NULL
clones	NULL
were	NULL
assayed	NULL
for	NULL
hGR	NULL
expression	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
tetracycline	NULL
,	NULL
and	NULL
clone	NULL
CEMtetGRHA	NULL
was	NULL
chosen	NULL
for	NULL
further	NULL
study	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
tetracycline	NULL
to	NULL
regulate	NULL
hGR	NULL
mRNA	NULL
expression	NULL
in	NULL
CEMtetGRHA	NULL
cells	NULL
was	NULL
determined	NULL
by	NULL
RT-PCR	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Forward	NULL
primers	NULL
A	NULL
and	NULL
C	NULL
,	NULL
which	NULL
are	NULL
specific	NULL
for	NULL
the	NULL
transfected	NULL
HA-tagged	NULL
hGR	NULL
gene	NULL
and	NULL
the	NULL
endogenous	NULL
mutant	NULL
GR753F	NULL
gene	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
reverse	NULL
primer	NULL
B	NULL
,	NULL
which	NULL
hybridizes	NULL
to	NULL
both	NULL
genes	NULL
,	NULL
were	NULL
used	NULL
to	NULL
amplify	NULL
mRNA	NULL
transcribed	NULL
from	NULL
the	NULL
endogenous	NULL
mutant	NULL
and	NULL
transfected	NULL
HA-tagged	NULL
hGR	NULL
genes	NULL
.	NULL

The	NULL
147-bp	NULL
product	NULL
from	NULL
the	NULL
endogenous	NULL
mutant	NULL
GR753F	NULL
gene	NULL
is	NULL
present	NULL
in	NULL
samples	NULL
prepared	NULL
from	NULL
both	NULL
parental	NULL
ICR27TK.3	NULL
and	NULL
transfected	NULL
CEMtetGRHA	NULL
cells	NULL
and	NULL
serves	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
for	NULL
the	NULL
efficiency	NULL
of	NULL
the	NULL
amplification	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
204-bp	NULL
product	NULL
from	NULL
the	NULL
transfected	NULL
gene	NULL
is	NULL
present	NULL
only	NULL
in	NULL
CEMtetGRHA	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
growth	NULL
of	NULL
CEMtetGRHA	NULL
cells	NULL
in	NULL
1	NULL
pg/ml	NULL
tetracycline	NULL
for	NULL
4	NULL
days	NULL
resulted	NULL
in	NULL
a	NULL
50	NULL
%	NULL
reduction	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
mRNA	NULL
from	NULL
the	NULL
transfected	NULL
gene	NULL
,	NULL
demonstrating	NULL
tetracycline-regulated	NULL
expression	NULL
of	NULL
hGR	NULL
mRNA	NULL
in	NULL
CEMtetGRHA	NULL
cells	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
regulation	NULL
of	NULL
hGR	NULL
protein	NULL
,	NULL
extracts	NULL
of	NULL
total	NULL
cell	NULL
protein	NULL
prepared	NULL
from	NULL
parental	NULL
ICR27TK.3	NULL
and	NULL
transfected	NULL
CEMtet-	NULL
ICR27TK.3	NULL
AGR/GRT75S3F	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Inducible	NULL
expression	NULL
of	NULL
HA-tagged	NULL
hGR	NULL
in	NULL
ICR27TK.3	NULL
cells	NULL
.	NULL

A	NULL
tetracycline-based	NULL
inducible	NULL
expression	NULL
system	NULL
was	NULL
used	NULL
to	NULL
express	NULL
HA-tagged	NULL
GR	NULL
in	NULL
glucocorticoid-resistant	NULL
ICR27TK.3	NULL
cells	NULL
.	NULL

Plasmid	NULL
pUHD15-1	NULL
neo	NULL
expressing	NULL
the	NULL
chimeric	NULL
transactivator	NULL
tTA	NULL
(	NULL
21	NULL
)	NULL
was	NULL
introduced	NULL
by	NULL
electroporation	NULL
,	NULL
and	NULL
stable	NULL
Geneticin-resistant	NULL
transfectants	NULL
were	NULL
selected	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Plasmid	NULL
pZeotetGRaHA17	NULL
,	NULL
which	NULL
expresses	NULL
the	NULL
HA-tagged	NULL
GR	NULL
downstream	NULL
of	NULL
a	NULL
heptameric	NULL
repeat	NULL
of	NULL
the	NULL
tet	NULL
operator	NULL
(	NULL
tetO	NULL
)	NULL
sequence	NULL
and	NULL
a	NULL
minimal	NULL
eukaryotic	NULL
promoter	NULL
(	NULL
ppCMV'-1	NULL
)	NULL
,	NULL
was	NULL
then	NULL
introduced	NULL
,	NULL
and	NULL
stable	NULL
transfectants	NULL
were	NULL
selected	NULL
in	NULL
medium	NULL
containing	NULL
zeocin	NULL
.	NULL

One	NULL
zeocin-resistant	NULL
transfectant	NULL
(	NULL
CEMtetGRHA	NULL
)	NULL
was	NULL
chosen	NULL
for	NULL
analysis	NULL
of	NULL
the	NULL
role	NULL
of	NULL
GR	NULL
autoinduction	NULL
in	NULL
glucocorticoid-induced	NULL
T-cell	NULL
apoptosis	NULL
.	NULL

710	NULL
Ab	NULL
region	NULL
P	NULL
HT	NULL
,	NULL
éZ|	NULL
<	NULL
—58	NULL
I	NULL
HA-tag	NULL
region	NULL
|	NULL
ne-	NULL
fammaaaaaeef	NULL
nnn	NULL
A	NULL
bp	NULL
ng	NULL
-100	NULL
-	NULL
60	NULL
-	NULL
40	NULL
-	NULL
20	NULL
300	NULL
<	NULL
--	NULL
-	NULL
GRHA	NULL
200	NULL
-	NULL
``	NULL
3s	NULL
--	NULL
GRL753F	NULL
100	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Tetracycline	NULL
represses	NULL
hGR	NULL
mRNA	NULL
expression	NULL
in	NULL
CEMItetGRHA	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
forward	NULL
primers	NULL
A	NULL
and	NULL
C	NULL
(	NULL
which	NULL
are	NULL
specific	NULL
for	NULL
the	NULL
HA-tagged	NULL
and	NULL
endogenous	NULL
mutant	NULL
GR	NULL
genes	NULL
,	NULL
respectively	NULL
)	NULL
were	NULL
used	NULL
in	NULL
combination	NULL
with	NULL
reverse	NULL
primer	NULL
B	NULL
for	NULL
RT-PCR	NULL
of	NULL
hGR	NULL
mRNA	NULL
expressed	NULL
from	NULL
the	NULL
transfected	NULL
wild-type	NULL
and	NULL
endogenous	NULL
mutant	NULL
hGR	NULL
genes	NULL
.	NULL

B	NULL
,	NULL
RT-PCR	NULL
based	NULL
quantification	NULL
of	NULL
HA-tagged	NULL
hGR	NULL
mRNA	NULL
.	NULL

Total	NULL
RNA	NULL
prepared	NULL
from	NULL
untransfected	NULL
ICR27TK.3	NULL
cells	NULL
(	NULL
Lane	NULL
2	NULL
)	NULL
or	NULL
CEMIetGRHA	NULL
cells	NULL
grown	NULL
for	NULL
4	NULL
days	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
Lane	NULL
3	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
Lane	NULL
4	NULL
)	NULL
of	NULL
1	NULL
pg/ml	NULL
tetracycline	NULL
was	NULL
amplified	NULL
by	NULL
RT-PCR	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Lanes	NULL
7	NULL
and	NULL
5	NULL
contain	NULL
a	NULL
100-bp	NULL
ladder	NULL
and	NULL
a	NULL
DNA	NULL
mass	NULL
ladder	NULL
,	NULL
respectively	NULL
.	NULL

GRHA	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-hGR	NULL
antibody	NULL
710	NULL
or	NULL
anti-HA	NULL
antibody	NULL
HA.11	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
showed	NULL
that	NULL
antibody	NULL
710	NULL
reacts	NULL
with	NULL
the	NULL
98-kDa	NULL
hGR	NULL
protein	NULL
present	NULL
in	NULL
the	NULL
human	NULL
B-cell	NULL
line	NULL
IM-9	NULL
that	NULL
contains	NULL
approximately	NULL
10°	NULL
receptors/cell	NULL
(	NULL
27	NULL
)	NULL
and	NULL
the	NULL
glucocorticoid-sensitive	NULL
T-cell	NULL
line	NULL
6TG1.1	NULL
,	NULL
which	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
steroid	NULL
,	NULL
expresses	NULL
both	NULL
the	NULL
mutant	NULL
L753F	NULL
hGR	NULL
protein	NULL
and	NULL
approximately	NULL
15,000-20,000	NULL
normal	NULL
receptors/cell	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Antibody	NULL
710	NULL
also	NULL
reacted	NULL
with	NULL
the	NULL
mutant	NULL
hGR	NULL
(	NULL
L753F	NULL
)	NULL
protein	NULL
present	NULL
in	NULL
both	NULL
parental	NULL
ICR27TK.3	NULL
and	NULL
transfected	NULL
CEMtetGRHA	NULL
cells	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
immunoreactivity	NULL
was	NULL
essentially	NULL
equal	NULL
in	NULL
extracts	NULL
prepared	NULL
from	NULL
these	NULL
two	NULL
cell	NULL
lines	NULL
and	NULL
was	NULL
approximately	NULL
half	NULL
that	NULL
present	NULL
in	NULL
extracts	NULL
prepared	NULL
from	NULL
glucocorticoid-sensitive	NULL
6TG1.1	NULL
cells	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
wild-type	NULL
gene	NULL
is	NULL
deleted	NULL
in	NULL
these	NULL
cells	NULL
and	NULL
indicating	NULL
that	NULL
there	NULL
is	NULL
no	NULL
reaction	NULL
of	NULL
antibody	NULL
710	NULL
with	NULL
the	NULL
HA-tagged	NULL
GR	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
antibody	NULL
HA.11	NULL
reacted	NULL
exclusively	NULL
with	NULL
HA-tagged	NULL
GR	NULL
in	NULL
1380	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1999	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

GR	NULL
AUTOREGULATION	NULL
AND	NULL
STEROID-INDUCED	NULL
CELL	NULL
DEATH	NULL
710	NULL
peptide	NULL
245	NULL
272	NULL
CKPLILPDTKPKIKDNGDLVLSSPSNVT	NULL
1	NULL
\	NULL
/	NULL
421	NULL
486	NULL
528	NULL
777	NULL
N-terminal	NULL
W	NULL
|	NULL
so	NULL
|	NULL
__|	NULL
LBD	NULL
]	NULL
HA	NULL
peptide	NULL
245	NULL
271	NULL
1	NULL
\	NULL
/	NULL
421	NULL
486	NULL
528	NULL
777	NULL
[	NULL
___	NULL
N-terminal	NULL
|	NULL
_|	NULL
[	NULL
beso	NULL
[	NULL
__|	NULL
LBD	NULL
|	NULL
B	NULL
es	NULL
C	NULL
<	NULL
&	NULL
[	NULL
ral	NULL
[	NULL
x	NULL
)	NULL
4	NULL
¥	NULL
J	NULL
yo	NULL
05	NULL
y-	NULL
to	NULL
>	NULL
)	NULL
E1	NULL
€	NULL
72	NULL
)	NULL
&	NULL
&	NULL
o	NULL
7	NULL
||	NULL
&	NULL
6	NULL
|g	NULL
=	NULL
7	NULL
E	NULL
C	NULL
[	NULL
r	NULL
]	NULL
E	NULL
tC	NULL
5	NULL
kDa	NULL
€	NULL
b	NULL
2	NULL
06	NULL
©	NULL
-	NULL
2	NULL
o	NULL
205	NULL
»	NULL
15+	NULL
emai	NULL
comms	NULL
=	NULL
>	NULL
-GRo	NULL
«	NULL
#	NULL
m	NULL
»	NULL
-GRHA	NULL
79.5	NULL
»	NULL
<	NULL
ommume	NULL
v	NULL
49.5	NULL
»	NULL
i	NULL
61	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Identification	NULL
of	NULL
HA-tagged	NULL
hGR	NULL
.	NULL

A	NULL
,	NULL
schematic	NULL
representation	NULL
of	NULL
the	NULL
replacement	NULL
of	NULL
the	NULL
28-residue	NULL
portion	NULL
of	NULL
the	NULL
NH	NULL
,	NULL
-terminal	NULL
domain	NULL
of	NULL
the	NULL
hGR	NULL
against	NULL
which	NULL
antibody	NULL
710	NULL
was	NULL
raised	NULL
with	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
HA	NULL
antigen	NULL
.	NULL

Although	NULL
not	NULL
indicated	NULL
,	NULL
T7	NULL
,	NULL
is	NULL
present	NULL
in	NULL
the	NULL
final	NULL
construct	NULL
.	NULL

B	NULL
and	NULL
C	NULL
,	NULL
protein	NULL
(	NULL
50	NULL
ug	NULL
)	NULL
isolated	NULL
from	NULL
IM-9	NULL
,	NULL
6TG1.1	NULL
,	NULL
ICR27TK.3	NULL
,	NULL
or	NULL
CEMItetGRHA	NULL
cells	NULL
was	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
the	NULL
hGR	NULL
was	NULL
visualized	NULL
using	NULL
antibody	NULL
710	NULL
(	NULL
B	NULL
)	NULL
or	NULL
HA.11	NULL
(	NULL
C	NULL
)	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

The	NULL
positions	NULL
of	NULL
wild-type	NULL
GRa	NULL
and	NULL
of	NULL
HA-tagged	NULL
GR	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
to	NULL
the	NULL
right	NULL
of	NULL
each	NULL
panel	NULL
.	NULL

transfected	NULL
CEMtetGRHA	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
;	NULL
there	NULL
was	NULL
no	NULL
reaction	NULL
with	NULL
either	NULL
mutant	NULL
L753F	NULL
or	NULL
wild-type	NULL
protein	NULL
in	NULL
ICR27TK.3	NULL
cells	NULL
or	NULL
in	NULL
6TG1.1	NULL
cells	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
as	NULL
little	NULL
as	NULL
0.05	NULL
pg/ml	NULL
tetracycline	NULL
to	NULL
the	NULL
growth	NULL
medium	NULL
resulted	NULL
in	NULL
a	NULL
50-75	NULL
%	NULL
reduction	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
immunoreactive	NULL
HA-tagged	NULL
hGR	NULL
protein	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
increasing	NULL
the	NULL
concentration	NULL
of	NULL
tetracycline	NULL
did	NULL
not	NULL
elicit	NULL
a	NULL
further	NULL
reduction	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
hGR	NULL
protein	NULL
expressed	NULL
.	NULL

Thus	NULL
,	NULL
regulation	NULL
of	NULL
hGR	NULL
expression	NULL
from	NULL
the	NULL
promoter	NULL
that	NULL
contains	NULL
the	NULL
heptameric	NULL
repeat	NULL
of	NULL
the	NULL
tetO	NULL
sequence	NULL
occurs	NULL
over	NULL
a	NULL
very	NULL
narrow	NULL
range	NULL
of	NULL
drug	NULL
con-centration	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
even	NULL
at	NULL
1	NULL
ug/ml	NULL
tetracycline	NULL
,	NULL
it	NULL
is	NULL
not	NULL
possible	NULL
to	NULL
fully	NULL
repress	NULL
hGR	NULL
expression	NULL
.	NULL

To	NULL
measure	NULL
the	NULL
intracellular	NULL
concentration	NULL
of	NULL
receptor	NULL
,	NULL
methasone	NULL
binding	NULL
assays	NULL
were	NULL
performed	NULL
on	NULL
intact	NULL
cells	NULL
.	NULL

Under	NULL
the	NULL
conditions	NULL
of	NULL
this	NULL
assay	NULL
,	NULL
there	NULL
is	NULL
virtually	NULL
no	NULL
binding	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
dexam-ethasone	NULL
to	NULL
mutant	NULL
L753F	NULL
receptors	NULL
(	NULL
Ref	NULL
.	NULL

28	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

CEMtetGRHA	NULL
cells	NULL
grown	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
tetracycline	NULL
expressed	NULL
approximately	NULL
48,000	NULL
receptors/cell	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cells	NULL
grown	NULL
in	NULL
1	NULL
ug/ml	NULL
tetracycline	NULL
expressed	NULL
only	NULL
15,000	NULL
binding	NULL
sites/cell	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

This	NULL
decrease	NULL
was	NULL
comparable	NULL
to	NULL
the	NULL
decrease	NULL
in	NULL
immunoreactive	NULL
protein	NULL
seen	NULL
by	NULL
immunoblotting	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
the	NULL
concentration	NULL
of	NULL
active	NULL
hGR	NULL
in	NULL
CEMtetGRHA	NULL
cells	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
tetracycline	NULL
corresponds	NULL
well	NULL
with	NULL
the	NULL
amount	NULL
of	NULL
functional	NULL
hGR	NULL
present	NULL
in	NULL
glucocorticoid-sensitive	NULL
6TG1.1	NULL
cells	NULL
before	NULL
and	NULL
18	NULL
h	NULL
after	NULL
glucocorticoid	NULL
treatment	NULL
.	NULL

Thus	NULL
,	NULL
tetracycline	NULL
regulation	NULL
of	NULL
hGR	NULL
expression	NULL
in	NULL
CEMtetGRHA	NULL
cells	NULL
is	NULL
a	NULL
suitable	NULL
system	NULL
for	NULL
evaluation	NULL
of	NULL
the	NULL
role	NULL
of	NULL
positive	NULL
hGR	NULL
autoregulation	NULL
in	NULL
glucocorticoid-induced	NULL
growth	NULL
arrest	NULL
and	NULL
cell	NULL
death	NULL
.	NULL

Effect	NULL
of	NULL
Receptor	NULL
Concentration	NULL
on	NULL
Glucocorticoid-induced	NULL
Growth	NULL
Arrest	NULL
and	NULL
Cell	NULL
Death	NULL
.	NULL

To	NULL
ascertain	NULL
the	NULL
role	NULL
of	NULL
receptor	NULL
concentration	NULL
on	NULL
glucocorticoid-induced	NULL
growth	NULL
arrest	NULL
,	NULL
CEMtetGRHA	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
1	NULL
ug/ml	NULL
tetracycline	NULL
were	NULL
grown	NULL
for	NULL
4	NULL
days	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
1	NULL
um	NULL
dexamethasone	NULL
.	NULL

Determination	NULL
of	NULL
the	NULL
cell	NULL
number	NULL
revealed	NULL
that	NULL
cells	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
tetracycline	NULL
(	NULL
15,000	NULL
receptors/cell	NULL
)	NULL
experienced	NULL
a	NULL
partial	NULL
growth	NULL
inhibition	NULL
in	NULL
response	NULL
to	NULL
steroid	NULL
.	NULL

This	NULL
was	NULL
greater	NULL
than	NULL
that	NULL
seen	NULL
after	NULL
the	NULL
treatment	NULL
of	NULL
steroid-resistant	NULL
ICR27TK.3	NULL
cells	NULL
but	NULL
was	NULL
substantially	NULL
less	NULL
that	NULL
seen	NULL
after	NULL
steroid	NULL
treatment	NULL
of	NULL
CEMtetGRHA	NULL
cells	NULL
grown	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
tetracycline	NULL
(	NULL
48,000	NULL
receptors/cell	NULL
)	NULL
,	NULL
which	NULL
experienced	NULL
a	NULL
75	NULL
%	NULL
reduction	NULL
in	NULL
growth	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Tetracycline	NULL
itself	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
either	NULL
hGR	NULL
expression	NULL
or	NULL
cell	NULL
growth	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
there	NULL
is	NULL
a	NULL
direct	NULL
correlation	NULL
between	NULL
receptor	NULL
concentration	NULL
and	NULL
the	NULL
steroid-induced	NULL
inhibition	NULL
of	NULL
cell	NULL
growth	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
receptor	NULL
concentration	NULL
on	NULL
cell	NULL
cycle	NULL
arrest	NULL
and	NULL
cell	NULL
death	NULL
was	NULL
investigated	NULL
by	NULL
flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
tetracycline	NULL
and	NULL
then	NULL
grown	NULL
for	NULL
48	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
1	NULL
um	NULL
dexamethasone	NULL
.	NULL

Growth	NULL
of	NULL
steroid-resistant	NULL
ICR27TK.3	NULL
cells	NULL
in	NULL
1	NULL
um	NULL
dexamethasone	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
ICR27TK.3	NULL
CEMtetGRHA	NULL
ia	NULL
...	NULL
|	NULL
ol	NULL
0.05	NULL
67	NULL
02	NULL
)	NULL
7	NULL
-o	NULL
1	NULL
)	NULL
|	NULL
2	NULL
#	NULL
21114	NULL
!	NULL

!	NULL

!	NULL

816	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Tetracycline	NULL
regulation	NULL
of	NULL
hGR	NULL
protein	NULL
expression	NULL
.	NULL

Extracts	NULL
(	NULL
50	NULL
pg	NULL
of	NULL
protein	NULL
)	NULL
prepared	NULL
from	NULL
untransfected	NULL
ICR27TK.3	NULL
cells	NULL
(	NULL
Lane	NULL
1	NULL
)	NULL
or	NULL
CEMtetGRHA	NULL
cells	NULL
grown	NULL
for	NULL
4	NULL
days	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
Lane	NULL
2	NULL
)	NULL
,	NULL
or	NULL
presence	NULL
(	NULL
Lanes	NULL
3-6	NULL
)	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
tetracycline	NULL
(	NULL
0.05-1.0	NULL
ug/ml	NULL
)	NULL
were	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
the	NULL
HA-tagged	NULL
hGR	NULL
was	NULL
visualized	NULL
with	NULL
antibody	NULL
HA.11	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

1381	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1999	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

GR	NULL
AUTOREGULATION	NULL
AND	NULL
STEROID-INDUCED	NULL
CELL	NULL
DEATH	NULL
60	NULL
receptors/cell	NULL
x	NULL
10°	NULL
0	NULL
05	NULL
A	NULL
.2	NULL
1	NULL
tetracycline	NULL
(	NULL
ug/ml	NULL
!	NULL
)	NULL

Fig	NULL
.	NULL

5	NULL
.	NULL

Tetracycline	NULL
regulation	NULL
of	NULL
[	NULL
*H	NULL
}	NULL
dexamethasone	NULL
binding	NULL
activity	NULL
in	NULL
GRHA	NULL
cells	NULL
.	NULL

CEMIctGRHA	NULL
cells	NULL
were	NULL
grown	NULL
for	NULL
4	NULL
days	NULL
in	NULL
medium	NULL
containing	NULL
various	NULL
concentrations	NULL
of	NULL
tetracycline	NULL
.	NULL

Ligand	NULL
binding	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
in	NULL
``	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

cell	NULL
cycle	NULL
distribution	NULL
,	NULL
and	NULL
no	NULL
apoptotic	NULL
cells	NULL
were	NULL
detected	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
absence	NULL
of	NULL
subdiploid	NULL
nuclei	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
steroid	NULL
treatment	NULL
of	NULL
CEMtetGRHA	NULL
cells	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
tetracycline	NULL
(	NULL
a	NULL
condition	NULL
approximating	NULL
the	NULL
initial	NULL
hGR	NULL
concentration	NULL
in	NULL
steroid-sensitive	NULL
6TG1.1	NULL
cells	NULL
)	NULL
resulted	NULL
in	NULL
only	NULL
a	NULL
small	NULL
decrease	NULL
in	NULL
the	NULL
proportion	NULL
of	NULL
cells	NULL
in	NULL
S	NULL
phase	NULL
,	NULL
with	NULL
no	NULL
substantial	NULL
increase	NULL
in	NULL
the	NULL
number	NULL
of	NULL
cells	NULL
with	NULL
a	NULL
subdiploid	NULL
amount	NULL
of	NULL
DNA	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
steroid	NULL
treatment	NULL
of	NULL
CEMtetGRHA	NULL
cells	NULL
grown	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
tetracycline	NULL
(	NULL
a	NULL
condition	NULL
approximating	NULL
the	NULL
concentration	NULL
of	NULL
hGR	NULL
in	NULL
6TG1.1	NULL
cells	NULL
after	NULL
24	NULL
h	NULL
of	NULL
steroid	NULL
treatment	NULL
)	NULL
elicited	NULL
both	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
S-phase	NULL
cells	NULL
and	NULL
a	NULL
substantial	NULL
number	NULL
of	NULL
apoptotic	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

A	NULL
comparable	NULL
result	NULL
was	NULL
obtained	NULL
when	NULL
apoptosis	NULL
was	NULL
assessed	NULL
by	NULL
examining	NULL
chromatin	NULL
fragmentation	NULL
;	NULL
there	NULL
was	NULL
substantially	NULL
more	NULL
internucleosomal	NULL
DNA	NULL
fragmentation	NULL
in	NULL
steroid-treated	NULL
cells	NULL
grown	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
tetracycline	NULL
than	NULL
in	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
tetracycline	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

When	NULL
growth	NULL
arrest	NULL
and	NULL
cell	NULL
death	NULL
were	NULL
examined	NULL
in	NULL
steroid-sensitive	NULL
6TG1.1	NULL
cells	NULL
in	NULL
which	NULL
the	NULL
hGR	NULL
is	NULL
autoinduced	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
steroid	NULL
treatment	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
seen	NULL
in	NULL
CEMtetGRHA	NULL
cells	NULL
grown	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
tetracycline	NULL
(	NULL
Figs	NULL
.	NULL

7	NULL
and	NULL
8	NULL
)	NULL
;	NULL
there	NULL
was	NULL
a	NULL
substantial	NULL
decrease	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
S-phase	NULL
cells	NULL
,	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
internucleosomal	NULL
DNA	NULL
fragmentation	NULL
,	NULL
and	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
dead	NULL
cells	NULL
with	NULL
less	NULL
than	NULL
a	NULL
G	NULL
,	NULL
content	NULL
of	NULL
DNA	NULL
.	NULL

Thus	NULL
,	NULL
glucocorticoid-induced	NULL
growth	NULL
arrest	NULL
and	NULL
cell	NULL
death	NULL
seem	NULL
to	NULL
require	NULL
hGR	NULL
concentrations	NULL
comparable	NULL
to	NULL
those	NULL
seen	NULL
after	NULL
receptor	NULL
autoinduction	NULL
.	NULL

DISCUSSION	NULL
In	NULL
most	NULL
cells	NULL
and	NULL
tissues	NULL
,	NULL
the	NULL
GR	NULL
is	NULL
negatively	NULL
autoregulated	NULL
by	NULL
both	NULL
transcriptional	NULL
and	NULL
posttranscriptional	NULL
mechanisms	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Such	NULL
negative	NULL
autoregulation	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
negative	NULL
feedback	NULL
loops	NULL
characteristic	NULL
of	NULL
many	NULL
endocrine	NULL
systems	NULL
.	NULL

However	NULL
,	NULL
we	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
hGR	NULL
mRNA	NULL
and	NULL
protein	NULL
are	NULL
positively	NULL
autoregulated	NULL
in	NULL
glucocorticoid-sensitive	NULL
6TG1.1	NULL
cells	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Positive	NULL
autoregulation	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
other	NULL
cells	NULL
programmed	NULL
to	NULL
die	NULL
in	NULL
response	NULL
to	NULL
steroids	NULL
(	NULL
16	NULL
,	NULL
17	NULL
,	NULL
31	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
increase	NULL
in	NULL
GR	NULL
could	NULL
provide	NULL
a	NULL
mechanism	NULL
for	NULL
amplifying	NULL
the	NULL
hormonal	NULL
signal	NULL
in	NULL
cells	NULL
destined	NULL
to	NULL
undergo	NULL
apoptosis	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
positive	NULL
autoregulation	NULL
in	NULL
steroid-induced	NULL
cell	NULL
death	NULL
,	NULL
the	NULL
hGR	NULL
gene	NULL
,	NULL
under	NULL
the	NULL
control	NULL
of	NULL
a	NULL
tetracycline-regulated	NULL
promoter	NULL
,	NULL
was	NULL
stably	NULL
transfected	NULL
into	NULL
cells	NULL
that	NULL
lack	NULL
functional	NULL
GR	NULL
.	NULL

Glucocorticoid	NULL
treatment	NULL
of	NULL
cells	NULL
grown	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
tetracycline	NULL
(	NULL
induced	NULL
)	NULL
resulted	NULL
in	NULL
the	NULL
accumulation	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
cell	NULL
division	NULL
,	NULL
and	NULL
increased	NULL
chromatin	NULL
fragmentation	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
the	NULL
response	NULL
was	NULL
qualitatively	NULL
similar	NULL
to	NULL
the	NULL
response	NULL
seen	NULL
in	NULL
6TG1.1	NULL
cells	NULL
in	NULL
which	NULL
expression	NULL
of	NULL
the	NULL
hGR	NULL
gene	NULL
is	NULL
controlled	NULL
by	NULL
its	NULL
own	NULL
promoter	NULL
.	NULL

Because	NULL
untreated	NULL
6TG1.1	NULL
cells	NULL
express	NULL
approximately	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
hGR	NULL
ligand	NULL
binding	NULL
activity	NULL
(	NULL
15,000	NULL
receptors/	NULL
cell	NULL
)	NULL
as	NULL
CEMtetGRHA	NULL
cells	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
tetracycline	NULL
(	NULL
24	NULL
)	NULL
and	NULL
because	NULL
the	NULL
2-3-fold	NULL
increase	NULL
in	NULL
hGR	NULL
protein	NULL
and	NULL
ligand	NULL
binding	NULL
activity	NULL
seen	NULL
after	NULL
the	NULL
removal	NULL
of	NULL
tetracycline	NULL
is	NULL
comparable	NULL
to	NULL
the	NULL
3-4-fold	NULL
increase	NULL
in	NULL
hGR	NULL
protein	NULL
seen	NULL
after	NULL
steroid	NULL
treatment	NULL
of	NULL
autoinducible	NULL
6TG1.1	NULL
cells	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
autoinduction	NULL
is	NULL
an	NULL
essential	NULL
component	NULL
of	NULL
steroid-induced	NULL
cell	NULL
death	NULL
in	NULL
human	NULL
leukemic	NULL
6TG1.1	NULL
cells	NULL
.	NULL

One	NULL
possible	NULL
complication	NULL
to	NULL
the	NULL
interpretation	NULL
of	NULL
these	NULL
results	NULL
is	NULL
that	NULL
in	NULL
replacing	NULL
the	NULL
epitope	NULL
used	NULL
to	NULL
generate	NULL
anti-hGR	NULL
antibody	NULL
710	NULL
with	NULL
a	NULL
trimer	NULL
of	NULL
the	NULL
HA	NULL
epitope	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
GR	NULL
was	NULL
reduced	NULL
,	NULL
thereby	NULL
requiring	NULL
increased	NULL
expression	NULL
of	NULL
the	NULL
HA-tagged	NULL
receptor	NULL
to	NULL
achieve	NULL
growth	NULL
arrest	NULL
and	NULL
cell	NULL
death	NULL
.	NULL

Two	NULL
factors	NULL
suggest	NULL
that	NULL
this	NULL
is	NULL
not	NULL
the	NULL
case	NULL
:	NULL
(	NULL
a	NULL
)	NULL
the	NULL
region	NULL
of	NULL
the	NULL
GR	NULL
that	NULL
was	NULL
replaced	NULL
is	NULL
downstream	NULL
from	NULL
the	NULL
strong	NULL
transactivating	NULL
function	NULL
(	NULL
7	NULL
,	NULL
)	NULL
present	NULL
in	NULL
the	NULL
NH	NULL
,	NULL
-terminal	NULL
domain	NULL
of	NULL
the	NULL
hGR	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
;	NULL
and	NULL
(	NULL
b	NULL
)	NULL
more	NULL
importantly	NULL
,	NULL
transient	NULL
transfection	NULL
of	NULL
the	NULL
HA-tagged	NULL
GR	NULL
gene	NULL
into	NULL
COS-7	NULL
cells	NULL
gave	NULL
the	NULL
same	NULL
level	NULL
of	NULL
glucocorticoid	NULL
induction	NULL
of	NULL
pMSG-CAT	NULL
and	NULL
the	NULL
same	NULL
level	NULL
of	NULL
glucocorticoid	NULL
repression	NULL
of	NULL
the	NULL
activator	NULL
protein	NULL
1-responsive	NULL
reporter	NULL
plasmid	NULL
-73	NULL
COL-CAT	NULL
as	NULL
did	NULL
wild-type	NULL
GR	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Although	NULL
positive	NULL
autoregulation	NULL
of	NULL
GR	NULL
expression	NULL
is	NULL
seen	NULL
in	NULL
several	NULL
cell	NULL
lines	NULL
sensitive	NULL
to	NULL
glucocorticoid-induced	NULL
cell	NULL
death	NULL
,	NULL
it	NULL
is	NULL
not	NULL
simply	NULL
an	NULL
in	NULL
vitro	NULL
phenomenon	NULL
restricted	NULL
to	NULL
such	NULL
cells	NULL
.	NULL

Positive	NULL
autoregulation	NULL
of	NULL
GR	NULL
expression	NULL
is	NULL
also	NULL
seen	NULL
in	NULL
several	NULL
regions	NULL
of	NULL
the	NULL
brain	NULL
,	NULL
indicating	NULL
that	NULL
it	NULL
is	NULL
not	NULL
a	NULL
sufficient	NULL
condition	NULL
for	NULL
steroid-induced	NULL
cell	NULL
death	NULL
(	NULL
34	NULL
)	NULL
.	NULL

There	NULL
has	NULL
been	NULL
only	NULL
limited	NULL
characterization	NULL
of	NULL
the	NULL
organization	NULL
and	NULL
regulation	NULL
of	NULL
the	NULL
hGR	NULL
promoter	NULL
(	NULL
35-39	NULL
)	NULL
.	NULL

Conse-quently	NULL
,	NULL
the	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
that	NULL
underlies	NULL
the	NULL
differential	NULL
autoregulation	NULL
of	NULL
hGR	NULL
expression	NULL
is	NULL
unclear	NULL
.	NULL

However	NULL
,	NULL
differential	NULL
autoregulation	NULL
of	NULL
the	NULL
closely	NULL
related	NULL
androgen	NULL
and	NULL
mineralocorticoid	NULL
receptors	NULL
has	NULL
also	NULL
been	NULL
observed	NULL
(	NULL
40-42	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
differential	NULL
tissue-specific	NULL
autoregulation	NULL
may	NULL
be	NULL
a	NULL
feature	NULL
common	NULL
to	NULL
other	NULL
members	NULL
of	NULL
the	NULL
nuclear	NULL
receptor	NULL
family	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
glucocorticoid-resistant	NULL
CEM-C1	NULL
cells	NULL
can	NULL
be	NULL
rendered	NULL
sensitive	NULL
to	NULL
glucocorticoid-induced	NULL
100	NULL
G	NULL
©	NULL
tg	NULL
75	NULL
-	NULL
-dex	NULL
®	NULL
3	NULL
3	NULL
50	NULL
+dex	NULL
se	NULL
25	NULL
0	NULL
.	NULL

+	NULL
.	NULL

tet	NULL
ICR	NULL
CEMtetGRHA	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Effect	NULL
of	NULL
hGR	NULL
concentration	NULL
on	NULL
cell	NULL
growth	NULL
.	NULL

ICR27TK.3	NULL
or	NULL
CEMtetGRHA	NULL
cells	NULL
grown	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
of	NULL
1	NULL
pg/ml	NULL
tetracycline	NULL
(	NULL
%	NULL
e7	NULL
)	NULL
were	NULL
treated	NULL
with	NULL
1	NULL
uM	NULL
dexamethasone	NULL
for	NULL
4	NULL
days	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
number	NULL
of	NULL
cells	NULL
in	NULL
dexamethasone-treated	NULL
cultures	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
untreated	NULL
controls	NULL
.	NULL

1382	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1999	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

GR	NULL
AUTOREGULATION	NULL
AND	NULL
STEROID-INDUCED	NULL
CELL	NULL
DEATH	NULL
A	NULL
a	NULL
S1	NULL
soo	NULL
sco	NULL
3	NULL
®	NULL
Be	NULL
3	NULL
3	NULL
5	NULL
$	NULL
,	NULL
:	NULL
2	NULL
5	NULL
gi	NULL
=	NULL
*	NULL
3	NULL
:	NULL
C	NULL
&	NULL
2	NULL
8	NULL
C	NULL
;	NULL
o	NULL
S	NULL
®	NULL
Channels	NULL
9°	NULL
°	NULL
°	NULL
channels	NULL
``	NULL
**	NULL
°	NULL
DNA	NULL
Content	NULL
DNA	NULL
Content	NULL
1	NULL
G4	NULL
5	NULL
b	NULL
g	NULL
a	NULL
E	NULL
g-	NULL
]	NULL
§	NULL
,	NULL
°	NULL
§*7	NULL
2	NULL
6	NULL
B	NULL
§	NULL
1	NULL
=	NULL
7	NULL
2	NULL
2_	NULL
|	NULL
o	NULL
$	NULL
=	NULL
0	NULL
&	NULL
7	NULL
o	NULL
©	NULL
7	NULL
o	NULL
3	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Effect	NULL
of	NULL
hGR	NULL
concentration	NULL
on	NULL
dexa-	NULL
N	NULL
1	NULL
methasone-induced	NULL
cell	NULL
cycle	NULL
arrest	NULL
.	NULL

Glucocorti-	NULL
E	NULL
coid-resistant	NULL
ICR27TK.3	NULL
cells	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
,	NULL
CEMtct-	NULL
o-p	NULL
°-	NULL
o	NULL
GRHA	NULL
cells	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
C	NULL
and	NULL
DD	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
E	NULL
and	NULL
F	NULL
)	NULL
of	NULL
1	NULL
ug/ml	NULL
tetracycline	NULL
,	NULL
or	NULL
glucocorticoid-sensitive	NULL
6TG1.1	NULL
cells	NULL
(	NULL
G	NULL
and	NULL
A	NULL
)	NULL
were	NULL
grown	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
A	NULL
,	NULL
C	NULL
,	NULL
£	NULL
,	NULL
and	NULL
G	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
B	NULL
,	NULL
D	NULL
,	NULL
F	NULL
,	NULL
and	NULL
H	NULL
)	NULL
of	NULL
1	NULL
um	NULL
dexamethasone	NULL
for	NULL
48	NULL
h.	NULL
Cells	NULL
were	NULL
stained	NULL
with	NULL
propidium	NULL
iodide	NULL
and	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
as	NULL
described	NULL
in	NULL
``	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

The	NULL
percentage	NULL
of	NULL
parti-	NULL
G4	NULL
1200	NULL
to	NULL
150	NULL
Channels	NULL
DNA	NULL
Content	NULL
to	NULL
150	NULL
Channels	NULL
DNA	NULL
Content	NULL
1200	NULL
cles	NULL
with	NULL
a	NULL
subdiploid	NULL
content	NULL
of	NULL
DNA	NULL
is	NULL
indicated	NULL
k	NULL
5	NULL
in	NULL
each	NULL
panel	NULL
.	NULL

$	NULL
a	NULL
$	NULL
€	NULL
.8	NULL
€	NULL
,	NULL
3	NULL
5	NULL
3	NULL
$	NULL
2	NULL
5	NULL
26	NULL
=	NULL
4	NULL
=s	NULL
C	NULL
:	NULL
o	NULL
°	NULL
3	NULL
®	NULL
o	NULL
°	NULL
1	NULL
0	NULL
°	NULL
do	NULL
150	NULL
0	NULL
Channels	NULL
Channels	NULL
DNA	NULL
Content	NULL
DNA	NULL
Content	NULL
1	NULL
G	NULL
%	NULL
H	NULL
5	NULL
``	NULL
-	NULL
5	NULL
A	NULL
7	NULL
E=	NULL
]	NULL
go	NULL
{	NULL
E	NULL
.s	NULL
S	NULL
8.5	NULL
3	NULL
Z	NULL
68-	NULL
2	NULL
%	NULL
=	NULL
Z	NULL
4	NULL
g	NULL
Z	NULL
a	NULL
8	NULL
|	NULL
8	NULL
:	NULL
a	NULL
°	NULL
Channels1	NULL
°	NULL
i	NULL
cell	NULL
death	NULL
by	NULL
overexpression	NULL
of	NULL
rat	NULL
GR	NULL
(	NULL
43	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
CEM-C1	NULL
cells	NULL
expressing	NULL
approximately	NULL
the	NULL
same	NULL
basal	NULL
level	NULL
of	NULL
GR	NULL
as	NULL
glucocorticoid-sensitive	NULL
6TG1.1	NULL
cells	NULL
exhibit	NULL
the	NULL
same	NULL
level	NULL
of	NULL
positive	NULL
hGR	NULL
autoregulation	NULL
as	NULL
their	NULL
glucocorticoid-sensitive	NULL
counterparts	NULL
(	NULL
13	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
both	NULL
CEM-C1	NULL
cells	NULL
and	NULL
murine	NULL
SAK8	NULL
cells	NULL
could	NULL
be	NULL
rendered	NULL
stably	NULL
1d0	NULL
150	NULL
Channels	NULL
DNA	NULL
Content	NULL
DNA	NULL
Content	NULL
sensitive	NULL
to	NULL
glucocorticoid-induced	NULL
apoptosis	NULL
by	NULL
treatment	NULL
with	NULL
5-aza-cytidine	NULL
(	NULL
44	NULL
,	NULL
45	NULL
)	NULL
,	NULL
presumably	NULL
as	NULL
a	NULL
result	NULL
of	NULL
the	NULL
demethylation	NULL
of	NULL
glucocorticoid-regulated	NULL
genes	NULL
involved	NULL
in	NULL
the	NULL
lytic	NULL
response	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
probable	NULL
that	NULL
the	NULL
relative	NULL
sensitivity	NULL
of	NULL
various	NULL
cells	NULL
and	NULL
cell	NULL
lines	NULL
to	NULL
glucocorticoid-induced	NULL
growth	NULL
arrest	NULL
and	NULL
cell	NULL
death	NULL
reflects	NULL
a	NULL
balance	NULL
between	NULL
the	NULL
amount	NULL
of	NULL
GR	NULL
present	NULL
and	NULL
the	NULL
sensitivity	NULL
of	NULL
the	NULL
1383	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1999	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

GR	NULL
AUTOREGULATION	NULL
AND	NULL
STEROID-INDUCED	NULL
CELL	NULL
DEATH	NULL
GTG1.1	NULL
ICR2ZTK.3	NULL
_	NULL
CEMZ/GRHA	NULL
fet	NULL
-o	NULL
oif	NULL
ort	NULL
-_	NULL
3	NULL
p	NULL
Dex	NULL
-	NULL
of	NULL
-	NULL
o	NULL
$	NULL
-	NULL
$	NULL
-	NULL
+	NULL
bp	NULL
bp	NULL
lilies	NULL
we	NULL
f	NULL
``	NULL
T	NULL
wee	NULL
-1,636	NULL
1000-	NULL
_-_	NULL
Ej	NULL
600	NULL
-	NULL
506	NULL
300	NULL
M1	NULL
10	NULL
2	NULL
3	NULL
4	NULL
506	NULL
7	NULL
8	NULL
M2	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

Effect	NULL
of	NULL
hGR	NULL
concentration	NULL
on	NULL
dexamethasone-induced	NULL
internucleosomal	NULL
DNA	NULL
fragmentation	NULL
.	NULL

Glucocorticoid-sensitive	NULL
6TG1.1	NULL
cells	NULL
(	NULL
Lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
glucocorticoid-resistant	NULL
ICR27TK.3	NULL
cells	NULL
(	NULL
Lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
or	NULL
CEMItetGRHA	NULL
cells	NULL
grown	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
Lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
Lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
of	NULL
1	NULL
pg/ml	NULL
tetracycline	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
Lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
7	NULL
)	NULL
,	NULL
or	NULL
presence	NULL
(	NULL
Lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
and	NULL
8	NULL
)	NULL
of	NULL
1	NULL
um	NULL
dexamethasone	NULL
for	NULL
48	NULL
h.	NULL
Internucleosomal	NULL
chromatin	NULL
fragmentation	NULL
was	NULL
assessed	NULL
by	NULL
agarose	NULL
gel	NULL
electro-phoresis	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Lanes	NULL
MJ	NULL
and	NULL
M2	NULL
contain	NULL
100-bp	NULL
and	NULL
1-kb	NULL
DNA	NULL
ladders	NULL
,	NULL
respectively	NULL
.	NULL

hormonally	NULL
responsive	NULL
genes	NULL
involved	NULL
in	NULL
the	NULL
lytic	NULL
response	NULL
to	NULL
regulation	NULL
by	NULL
GR	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
tetracycline	NULL
,	NULL
relatively	NULL
high	NULL
levels	NULL
of	NULL
hGR	NULL
expression	NULL
were	NULL
observed	NULL
.	NULL

However	NULL
,	NULL
the	NULL
growth	NULL
of	NULL
stable	NULL
transfectants	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
tetracycline	NULL
did	NULL
not	NULL
result	NULL
in	NULL
complete	NULL
repression	NULL
of	NULL
hGR	NULL
expression	NULL
.	NULL

hGR	NULL
mRNA	NULL
,	NULL
protein	NULL
,	NULL
and	NULL
ligand	NULL
binding	NULL
activity	NULL
were	NULL
all	NULL
reduced	NULL
to	NULL
approximately	NULL
30-50	NULL
%	NULL
of	NULL
the	NULL
amount	NULL
seen	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
antibiotic	NULL
.	NULL

The	NULL
reason	NULL
for	NULL
this	NULL
high	NULL
level	NULL
of	NULL
repressed	NULL
expression	NULL
is	NULL
unclear	NULL
.	NULL

However	NULL
,	NULL
when	NULL
CV-1	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
a	NULL
tTA	NULL
expression	NULL
vector	NULL
,	NULL
a	NULL
hGR-responsive	NULL
reporter	NULL
plasmid	NULL
,	NULL
and	NULL
a	NULL
fefO-containing	NULL
hGR	NULL
expression	NULL
vector	NULL
,	NULL
a	NULL
similar	NULL
inability	NULL
to	NULL
fully	NULL
repress	NULL
hGR	NULL
activity	NULL
was	NULL
observed	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
high	NULL
level	NULL
of	NULL
repressed	NULL
hGR	NULL
expression	NULL
in	NULL
CEMtetGRHA	NULL
cells	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
tetracycline	NULL
is	NULL
not	NULL
a	NULL
T	NULL
cell-specific	NULL
phenomenon	NULL
or	NULL
a	NULL
function	NULL
of	NULL
the	NULL
site	NULL
of	NULL
integration	NULL
.	NULL

Rather	NULL
,	NULL
it	NULL
seems	NULL
to	NULL
be	NULL
a	NULL
function	NULL
of	NULL
the	NULL
strong	NULL
modified	NULL
cytomegalovirus	NULL
promoter	NULL
used	NULL
to	NULL
achieve	NULL
high	NULL
level	NULL
expression	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
tetracycline	NULL
.	NULL

Significant	NULL
levels	NULL
of	NULL
repressed	NULL
expression	NULL
have	NULL
been	NULL
seen	NULL
in	NULL
other	NULL
systems	NULL
as	NULL
well	NULL
(	NULL
46	NULL
)	NULL
and	NULL
probably	NULL
account	NULL
for	NULL
the	NULL
small	NULL
amount	NULL
of	NULL
cell	NULL
cycle	NULL
perturbation	NULL
and	NULL
chromatin	NULL
fragmentation	NULL
seen	NULL
after	NULL
steroid	NULL
treatment	NULL
of	NULL
CEMtetGRHA	NULL
cells	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
tetracycline	NULL
.	NULL

Unlike	NULL
other	NULL
stimuli	NULL
that	NULL
induce	NULL
programmed	NULL
cell	NULL
death	NULL
,	NULL
glucocorticoid-induced	NULL
lymphocytolysis	NULL
requires	NULL
ongoing	NULL
protein	NULL
synthesis	NULL
(	NULL
20	NULL
,	NULL
47-49	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
either	NULL
the	NULL
synthesis	NULL
of	NULL
new	NULL
protein	NULL
or	NULL
the	NULL
continuous	NULL
presence	NULL
of	NULL
a	NULL
labile	NULL
protein	NULL
is	NULL
required	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
the	NULL
labile	NULL
inhibitory	NULL
factor	NULL
IxBa	NULL
is	NULL
induced	NULL
by	NULL
glucocorticoids	NULL
in	NULL
6TG1.1	NULL
cells	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
this	NULL
factor	NULL
and	NULL
the	NULL
accompanying	NULL
repression	NULL
of	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
activity	NULL
could	NULL
contribute	NULL
to	NULL
steroid-induced	NULL
cell	NULL
death	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
results	NULL
presented	NULL
here	NULL
suggest	NULL
that	NULL
the	NULL
synthesis	NULL
of	NULL
new	NULL
hGR	NULL
protein	NULL
is	NULL
also	NULL
required	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
requirement	NULL
for	NULL
new	NULL
protein	NULL
synthesis	NULL
could	NULL
reflect	NULL
,	NULL
in	NULL
part	NULL
,	NULL
the	NULL
requisite	NULL
autoinduction	NULL
of	NULL
hGR	NULL
expression	NULL
.	NULL

If	NULL
this	NULL
is	NULL
the	NULL
case	NULL
,	NULL
then	NULL
there	NULL
may	NULL
be	NULL
more	NULL
than	NULL
one	NULL
component	NULL
whose	NULL
induction	NULL
is	NULL
required	NULL
for	NULL
steroid-induced	NULL
cell	NULL
death	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
that	NULL
autoinduction	NULL
of	NULL
hGR	NULL
expression	NULL
is	NULL
a	NULL
necessary	NULL
component	NULL
of	NULL
glucocorticoid-induced	NULL
cell	NULL
death	NULL
in	NULL
human	NULL
leukemic	NULL
CEM	NULL
cells	NULL
in	NULL
culture	NULL
.	NULL

Studies	NULL
examining	NULL
the	NULL
relationship	NULL
between	NULL
hGR	NULL
concentration	NULL
and	NULL
clinical	NULL
response	NULL
in	NULL
human	NULL
leukemic	NULL
cells	NULL
obtained	NULL
directly	NULL
from	NULL
patients	NULL
have	NULL
not	NULL
found	NULL
the	NULL
same	NULL
strong	NULL
positive	NULL
correlation	NULL
between	NULL
receptor	NULL
concentration	NULL
and	NULL
response	NULL
seen	NULL
for	NULL
estrogen	NULL
receptors	NULL
in	NULL
breast	NULL
cancer	NULL
(	NULL
5-11	NULL
)	NULL
.	NULL

However	NULL
,	NULL
these	NULL
studies	NULL
examined	NULL
intracellular	NULL
hGR	NULL
concentration	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
hormone	NULL
.	NULL

Thus	NULL
,	NULL
if	NULL
autoinduction	NULL
of	NULL
hGR	NULL
expression	NULL
is	NULL
a	NULL
necessary	NULL
component	NULL
of	NULL
the	NULL
therapeutic	NULL
response	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
strong	NULL
correlation	NULL
between	NULL
receptor	NULL
concentration	NULL
and	NULL
clinical	NULL
response	NULL
is	NULL
due	NULL
to	NULL
the	NULL
measurement	NULL
of	NULL
basal	NULL
levels	NULL
rather	NULL
than	NULL
induced	NULL
levels	NULL
of	NULL
hGR	NULL
expression	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Vanderbilt	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Micsfeld	NULL
,	NULL
R.	NULL
,	NULL
Maler	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Yamamoto	NULL
,	NULL
K.	NULL
R.	NULL
Intracellular	NULL
receptor	NULL
concentration	NULL
limits	NULL
glucocorticoid-dependent	NULL
enhancer	NULL
activity	NULL
.	NULL

Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

,	NULL
7	NULL
:	NULL
68-74	NULL
,	NULL
1987	NULL
.	NULL

2	NULL
.	NULL

Gehring	NULL
,	NULL
U.	NULL
,	NULL
Mugele	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Ulrich	NULL
,	NULL
J	NULL
.	NULL

Cellular	NULL
receptor	NULL
levels	NULL
and	NULL
glucocorticoid	NULL
responsiveness	NULL
of	NULL
lymphoma	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Endocrinol	NULL
.	NULL

,	NULL
36	NULL
:	NULL
107-113	NULL
,	NULL
1984	NULL
.	NULL

3	NULL
.	NULL

Bourgeois	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Newby	NULL
,	NULL
R.	NULL
F.	NULL
Diploid	NULL
and	NULL
haploid	NULL
states	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
gene	NULL
of	NULL
mouse	NULL
lymphoid	NULL
cell	NULL
lines	NULL
.	NULL

Cell	NULL
,	NULL
17	NULL
:	NULL
423-430	NULL
,	NULL
1977	NULL
.	NULL

4	NULL
.	NULL

Chapman	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Askew	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Kuscuoglu	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Miesfeld	NULL
,	NULL
R.	NULL
L.	NULL
Transcriptional	NULL
control	NULL
of	NULL
steroid-regulated	NULL
apoptosis	NULL
in	NULL
murine	NULL
thymoma	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

,	NULL
10	NULL
:	NULL
967-978	NULL
,	NULL
1996	NULL
.	NULL

5	NULL
.	NULL

Weiss	NULL
,	NULL
C.	NULL
,	NULL
Ho	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Hiller	NULL
,	NULL
E.	NULL
,	NULL
Thiel	NULL
,	NULL
E.	NULL
,	NULL
Schlag	NULL
,	NULL
R.	NULL
,	NULL
Lipp	NULL
,	NULL
T.	NULL
,	NULL
Herrmann	NULL
,	NULL
R.	NULL
,	NULL
Musch	NULL
,	NULL
E.	NULL
,	NULL
Termander	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Hunstein	NULL
,	NULL
W.	NULL
Prognostic	NULL
significance	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
determination	NULL
in	NULL
patients	NULL
with	NULL
chronic	NULL
lymphocytic	NULL
leukemia	NULL
and	NULL
immunocy-toma	NULL
:	NULL
lack	NULL
of	NULL
a	NULL
positive	NULL
correlation	NULL
between	NULL
receptor	NULL
levels	NULL
and	NULL
clinical	NULL
responsive-ness	NULL
.	NULL

Leuk	NULL
,	NULL
Res	NULL
.	NULL

,	NULL
14	NULL
:	NULL
327-332	NULL
,	NULL
1990	NULL
.	NULL

6	NULL
.	NULL

Kato	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
Quddus	NULL
,	NULL
F.	NULL
F.	NULL
,	NULL
Shuster	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Boyett	NULL
,	NULL
J.	NULL
,	NULL
Pullen	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Borowitz	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Whitehead	NULL
,	NULL
V.	NULL
M.	NULL
,	NULL
Crist	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
and	NULL
Leventhal	NULL
,	NULL
B.	NULL
G.	NULL
High	NULL
glucocorticoid	NULL
receptor	NULL
content	NULL
of	NULL
leukemic	NULL
blasts	NULL
is	NULL
a	NULL
favorable	NULL
prognostic	NULL
factor	NULL
in	NULL
childhood	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Blood	NULL
,	NULL
82	NULL
:	NULL
2304-2309	NULL
,	NULL
1993	NULL
.	NULL

7	NULL
.	NULL

Tacobelli	NULL
,	NULL
S.	NULL
,	NULL
Marchetti	NULL
,	NULL
P.	NULL
,	NULL
De	NULL
Rossi	NULL
,	NULL
G.	NULL
,	NULL
Mandelli	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Gentiloni	NULL
,	NULL
N.	NULL
Glucocorticoid	NULL
receptors	NULL
predict	NULL
response	NULL
to	NULL
combination	NULL
chemotherapy	NULL
in	NULL
patients	NULL
with	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Oncology	NULL
(	NULL
Basel	NULL
)	NULL
,	NULL
44	NULL
:	NULL
13-16	NULL
,	NULL
1987	NULL
.	NULL

8	NULL
.	NULL

Pui	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Dahl	NULL
,	NULL
G.	NULL
V.	NULL
,	NULL
Rivera	NULL
,	NULL
G.	NULL
,	NULL
Murphy	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
and	NULL
Costlow	NULL
,	NULL
M.	NULL
E.	NULL
The	NULL
relationship	NULL
of	NULL
blast	NULL
cell	NULL
glucocorticoid	NULL
receptor	NULL
levels	NULL
to	NULL
response	NULL
to	NULL
single-agent	NULL
steroid	NULL
trial	NULL
and	NULL
remission	NULL
response	NULL
in	NULL
children	NULL
with	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Leuk	NULL
.	NULL

Res	NULL
.	NULL

,	NULL
8	NULL
:	NULL
579-585	NULL
,	NULL
1984	NULL
.	NULL

9	NULL
.	NULL

Pui	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
and	NULL
Costlow	NULL
,	NULL
M.	NULL
E.	NULL
Sequential	NULL
studies	NULL
of	NULL
lymphoblast	NULL
glucocorticoid	NULL
receptor	NULL
levels	NULL
at	NULL
diagnosis	NULL
and	NULL
relapse	NULL
in	NULL
childhood	NULL
leukemia	NULL
:	NULL
an	NULL
update	NULL
.	NULL

Leuk	NULL
.	NULL

Res	NULL
.	NULL

,	NULL
10	NULL
:	NULL
227-229	NULL
,	NULL
1986	NULL
.	NULL

10	NULL
.	NULL

Pui	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Ochs	NULL
,	NULL
J.	NULL
,	NULL
Kalwinsky	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
and	NULL
Costlow	NULL
,	NULL
M.	NULL
E.	NULL
Impact	NULL
of	NULL
treatment	NULL
efficacy	NULL
on	NULL
the	NULL
prognostic	NULL
value	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
levels	NULL
in	NULL
childhood	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Leuk	NULL
.	NULL

Res	NULL
.	NULL

,	NULL
8	NULL
:	NULL
345-350	NULL
,	NULL
1984	NULL
.	NULL

11	NULL
.	NULL

Pui	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Costlow	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Kalwinsky	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
and	NULL
Dahl	NULL
,	NULL
G.	NULL
V.	NULL
Glucocorticoid	NULL
receptors	NULL
in	NULL
childhood	NULL
acute	NULL
non-lymphocytic	NULL
leukemia	NULL
.	NULL

Leuk	NULL
.	NULL

Res	NULL
.	NULL

,	NULL
7	NULL
:	NULL
11-16	NULL
,	NULL
1983	NULL
.	NULL

12	NULL
.	NULL

Eisen	NULL
,	NULL
L.	NULL
P.	NULL
,	NULL
Elsasser	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
and	NULL
Harmon	NULL
,	NULL
J.	NULL
M.	NULL
Positive	NULL
regulation	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
in	NULL
human	NULL
T-cells	NULL
sensitive	NULL
to	NULL
the	NULL
cytolytic	NULL
effects	NULL
of	NULL
glucocorticoids	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
263	NULL
:	NULL
12044-12048	NULL
,	NULL
1988	NULL
.	NULL

13	NULL
.	NULL

Denton	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Eisen	NULL
,	NULL
L.	NULL
P.	NULL
,	NULL
Elsasser	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
and	NULL
Harmon	NULL
,	NULL
J.	NULL
M.	NULL
Differential	NULL
autoregulation	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
expression	NULL
in	NULL
human	NULL
T-cell	NULL
and	NULL
B-cell	NULL
lines	NULL
.	NULL

Endocrinology	NULL
,	NULL
133	NULL
:	NULL
248-256	NULL
,	NULL
1993	NULL
.	NULL

14	NULL
.	NULL

Ashraf	NULL
,	NULL
J.	NULL
,	NULL
Kunapuli	NULL
,	NULL
S.	NULL
,	NULL
Chilton	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
E.	NULL
B.	NULL
Cortivazol	NULL
mediated	NULL
induction	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
messenger	NULL
ribonucleic	NULL
acid	NULL
in	NULL
wild-type	NULL
and	NULL
dexamethasone-resistant	NULL
human	NULL
leukemic	NULL
(	NULL
CEM	NULL
)	NULL
cells	NULL
.	NULL

J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
38	NULL
:	NULL
561-568	NULL
,	NULL
1991	NULL
.	NULL

15	NULL
.	NULL

Antakly	NULL
,	NULL
T.	NULL
,	NULL
Thompson	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
and	NULL
O'Donnell	NULL
,	NULL
D.	NULL
Demonstration	NULL
of	NULL
the	NULL
intracellular	NULL
localization	NULL
and	NULL
up-regulation	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
by	NULL
in	NULL
site	NULL
hybridization	NULL
and	NULL
immunocytochemistry	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
49	NULL
:	NULL
2230-2234	NULL
,	NULL
1989	NULL
.	NULL

16	NULL
.	NULL

Barrett	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Vig	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Vedeckis	NULL
,	NULL
W.	NULL
V.	NULL
Coordinate	NULL
regulation	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
and	NULL
c-jun	NULL
gene	NULL
expression	NULL
is	NULL
cell	NULL
type-specific	NULL
and	NULL
exhibits	NULL
differential	NULL
hormonal	NULL
sensitivity	NULL
for	NULL
down-	NULL
and	NULL
up-regulation	NULL
.	NULL

Biochemistry	NULL
,	NULL
35	NULL
:	NULL
9746-9753	NULL
,	NULL
1996	NULL
.	NULL

17	NULL
.	NULL

Gomi	NULL
,	NULL
M.	NULL
,	NULL
Moriwaki	NULL
,	NULL
K.	NULL
,	NULL
Katagiri	NULL
,	NULL
S.	NULL
,	NULL
Kurata	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
E.	NULL
B.	NULL
Glucocorticoid	NULL
effects	NULL
on	NULL
myeloma	NULL
cells	NULL
in	NULL
culture	NULL
:	NULL
correlation	NULL
of	NULL
growth	NULL
inhibition	NULL
with	NULL
induction	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
messenger	NULL
RNA	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
50	NULL
:	NULL
1873-1878	NULL
,	NULL
1990	NULL
.	NULL

18	NULL
.	NULL

Powers	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Hillmann	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Tang	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
and	NULL
Harmon	NULL
,	NULL
J.	NULL
M.	NULL
Cloning	NULL
and	NULL
expression	NULL
of	NULL
mutant	NULL
glucocorticoid	NULL
receptors	NULL
from	NULL
glucocorticoid-sensitive	NULL
and	NULL
glucocorticoid-resistant	NULL
human	NULL
leukemic	NULL
cells	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
53	NULL
:	NULL
4059-4065	NULL
,	NULL
1993	NULL
.	NULL

1384	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1999	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

GR	NULL
AUTOREGULATION	NULL
AND	NULL
STEROID-INDUCED	NULL
CELL	NULL
DEATH	NULL
Liu	NULL
,	NULL
W.	NULL
,	NULL
Hillmann	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
and	NULL
Harmon	NULL
,	NULL
J.	NULL
M.	NULL
Hormone-independent	NULL
repression	NULL
of	NULL
AP-1-inducible	NULL
collagenase	NULL
promoter	NULL
activity	NULL
by	NULL
glucocorticoid	NULL
receptors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
:	NULL
1005-1013	NULL
,	NULL
1995	NULL
.	NULL

Ramdas	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Harmon	NULL
,	NULL
J.	NULL
M.	NULL
Glucocorticoid-induced	NULL
apoptosis	NULL
and	NULL
regulation	NULL
of	NULL
NF-kB	NULL
activity	NULL
in	NULL
human	NULL
leukemic	NULL
T	NULL
cells	NULL
.	NULL

Endocrinology	NULL
,	NULL
139	NULL
:	NULL
3813-3821	NULL
,	NULL
1998	NULL
.	NULL

Gossen	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Bujard	NULL
,	NULL
H.	NULL
Tight	NULL
control	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
mammalian	NULL
cells	NULL
by	NULL
tetracycline-responsive	NULL
promoters	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
89	NULL
:	NULL
5547-5551	NULL
,	NULL
1992	NULL
.	NULL

Resnitzky	NULL
,	NULL
D.	NULL
,	NULL
Gossen	NULL
,	NULL
M.	NULL
,	NULL
Bujard	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Reed	NULL
,	NULL
S.	NULL
I	NULL
.	NULL

Acceleration	NULL
of	NULL
the	NULL
G	NULL
;	NULL
/S	NULL
phase	NULL
transition	NULL
by	NULL
expression	NULL
of	NULL
cyclins	NULL
D1	NULL
and	NULL
E	NULL
with	NULL
an	NULL
inducible	NULL
system	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
14	NULL
:	NULL
1669-1679	NULL
,	NULL
1994	NULL
.	NULL

Hollenberg	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Weinberger	NULL
,	NULL
C.	NULL
,	NULL
Ong	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Cerelli	NULL
,	NULL
G.	NULL
,	NULL
Oro	NULL
,	NULL
A.	NULL
,	NULL
Lebo	NULL
,	NULL
R.	NULL
,	NULL
Thompson	NULL
,	NULL
BE	NULL
.	NULL

B.	NULL
,	NULL
Rosenfeld	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
Primary	NULL
structure	NULL
and	NULL
expression	NULL
of	NULL
a	NULL
functional	NULL
human	NULL
glucocorticoid	NULL
receptor	NULL
cDNA	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
318	NULL
:	NULL
635-641	NULL
,	NULL
1985	NULL
.	NULL

Harmon	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
E.	NULL
B	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
dexamethasone-resistant	NULL
mutants	NULL
from	NULL
human	NULL
lymphoid	NULL
cell	NULL
line	NULL
CEM-C7	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
1	NULL
:	NULL
512-521	NULL
,	NULL
1981	NULL
.	NULL

Gorczyca	NULL
,	NULL
W.	NULL
,	NULL
Gong	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Darzynkiewicz	NULL
,	NULL
Z	NULL
.	NULL

Detection	NULL
of	NULL
DNA	NULL
strand	NULL
breaks	NULL
in	NULL
individual	NULL
apoptotic	NULL
cells	NULL
by	NULL
the	NULL
#	NULL
7	NULL
:	NULL
sifu	NULL
terminal	NULL
deoxynucleotidy	NULL
]	NULL
transferase	NULL
and	NULL
nick	NULL
translation	NULL
assays	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
53	NULL
:	NULL
1945-1951	NULL
,	NULL
1993	NULL
.	NULL

Palmer	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Hukku	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Harmon	NULL
,	NULL
J.	NULL
M.	NULL
Human	NULL
glucocorticoid	NULL
receptor	NULL
gene	NULL
deletion	NULL
following	NULL
exposure	NULL
to	NULL
cancer	NULL
chemotherapeutic	NULL
drugs	NULL
and	NULL
chemical	NULL
muta-gens	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
52	NULL
:	NULL
6612-6618	NULL
,	NULL
1992	NULL
.	NULL

Harmon	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Eisen	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Brower	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
Simons	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
Jr.	NULL
,	NULL
Langley	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
E.	NULL
B	NULL
.	NULL

Identification	NULL
of	NULL
human	NULL
leukemic	NULL
glucocorticoid	NULL
receptors	NULL
using	NULL
affinity	NULL
labeling	NULL
and	NULL
anti-human	NULL
glucocorticoid	NULL
receptor	NULL
antibodies	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
44	NULL
:	NULL
4540-4547	NULL
,	NULL
1984	NULL
.	NULL

Palmer	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
and	NULL
Harmon	NULL
,	NULL
J.	NULL
M.	NULL
Biochemical	NULL
evidence	NULL
that	NULL
glucocorticoid-sensitive	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
the	NULL
human	NULL
leukemic	NULL
cell	NULL
line	NULL
CCRF-CEM	NULL
express	NULL
a	NULL
normal	NULL
and	NULL
a	NULL
mutant	NULL
glucocorticoid	NULL
receptor	NULL
gene	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
57	NULL
:	NULL
5224-5231	NULL
,	NULL
1991	NULL
.	NULL

Burnstein	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Bellingham	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Jewell	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Powell-Oliver	NULL
,	NULL
F.	NULL
E.	NULL
,	NULL
and	NULL
Cidlowski	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Autoregulation	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
gene	NULL
expression	NULL
.	NULL

Steroids	NULL
,	NULL
56	NULL
:	NULL
52-58	NULL
,	NULL
1991	NULL
.	NULL

Schmidt	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
and	NULL
Meyer	NULL
,	NULL
A.	NULL
S.	NULL
Autoregulation	NULL
of	NULL
corticosteroid	NULL
receptors	NULL
:	NULL
how	NULL
,	NULL
when	NULL
,	NULL
where	NULL
,	NULL
and	NULL
why	NULL
?	NULL

Receptor	NULL
,	NULL
4	NULL
:	NULL
229-257	NULL
,	NULL
1994	NULL
.	NULL

Vig	NULL
,	NULL
E.	NULL
,	NULL
Barrett	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
and	NULL
Vedeckis	NULL
,	NULL
W.	NULL
V.	NULL
Coordinate	NULL
regulation	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
and	NULL
c-jun	NULL
mRNA	NULL
levels	NULL
:	NULL
evidence	NULL
for	NULL
cross-talk	NULL
between	NULL
two	NULL
signaling	NULL
pathways	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
.	NULL

Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

,	NULL
8	NULL
:	NULL
1336-1346	NULL
,	NULL
1994	NULL
.	NULL

Hollenberg	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
Multiple	NULL
and	NULL
cooperative	NULL
frans-activation	NULL
domains	NULL
of	NULL
the	NULL
human	NULL
glucocorticoid	NULL
receptor	NULL
.	NULL

Cell	NULL
,	NULL
55	NULL
:	NULL
899-906	NULL
,	NULL
1988	NULL
.	NULL

Dahlman-Wright	NULL
,	NULL
K.	NULL
,	NULL
T.	NULL
,	NULL
McEwan	NULL
,	NULL
I.	NULL
J.	NULL
,	NULL
Gustafsson	NULL
,	NULL
J	NULL
.	NULL

A	NULL
,	NULL
and	NULL
Wright	NULL
,	NULL
A.	NULL
P.	NULL
H.	NULL
Delineation	NULL
of	NULL
a	NULL
small	NULL
region	NULL
within	NULL
the	NULL
major	NULL
transactivation	NULL
domain	NULL
of	NULL
the	NULL
human	NULL
glucocorticoid	NULL
receptor	NULL
that	NULL
mediates	NULL
transactivation	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
97	NULL
:	NULL
1619-1623	NULL
,	NULL
1994	NULL
.	NULL

Sheppard	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
Roberts	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Blum	NULL
,	NULL
M.	NULL
Differential	NULL
regulation	NULL
of	NULL
type	NULL
II	NULL
corticosteroid	NULL
receptor	NULL
messenger	NULL
ribonucleic	NULL
acid	NULL
expression	NULL
in	NULL
the	NULL
rat	NULL
anterior	NULL
pituitary	NULL
and	NULL
hippocampus	NULL
.	NULL

Endocrinology	NULL
,	NULL
127	NULL
:	NULL
431-439	NULL
,	NULL
1990	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

1385	NULL
Zong	NULL
,	NULL
J.	NULL
,	NULL
Asbraf	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
E.	NULL
B	NULL
.	NULL

The	NULL
promoter	NULL
and	NULL
first	NULL
,	NULL
untranslated	NULL
exon	NULL
of	NULL
the	NULL
human	NULL
glucocorticoid	NULL
receptor	NULL
gene	NULL
are	NULL
GC	NULL
rich	NULL
but	NULL
lack	NULL
consensus	NULL
glucocorticoid	NULL
receptor	NULL
element	NULL
sites	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
10	NULL
:	NULL
5580-5585	NULL
,	NULL
1990	NULL
.	NULL

Encio	NULL
,	NULL
I.	NULL
J.	NULL
,	NULL
and	NULL
Detera-Wadleigh	NULL
,	NULL
S.	NULL
D.	NULL
The	NULL
genomic	NULL
structure	NULL
of	NULL
the	NULL
human	NULL
glucocorticoid	NULL
receptor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
266	NULL
:	NULL
7182-7188	NULL
,	NULL
1991	NULL
.	NULL

Govindan	NULL
,	NULL
M.	NULL
V.	NULL
,	NULL
Pothier	NULL
,	NULL
F.	NULL
,	NULL
Leclerc	NULL
,	NULL
S.	NULL
,	NULL
Palaniswami	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Xie	NULL
,	NULL
B	NULL
.	NULL

Human	NULL
glucocorticoid	NULL
receptor	NULL
gene	NULL
promotor	NULL
:	NULL
homologous	NULL
down-regulation	NULL
.	NULL

J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
40	NULL
:	NULL
317-323	NULL
,	NULL
1991	NULL
.	NULL

Nobukuni	NULL
,	NULL
Y.	NULL
,	NULL
Smith	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Hager	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
and	NULL
Detera-Wadleigh	NULL
,	NULL
S.	NULL
D.	NULL
Characterization	NULL
of	NULL
the	NULL
human	NULL
glucocorticoid	NULL
receptor	NULL
promoter	NULL
.	NULL

Biochemistry	NULL
,	NULL
34	NULL
:	NULL
8207-8214	NULL
,	NULL
1995	NULL
.	NULL

Warriar	NULL
,	NULL
N.	NULL
,	NULL
Page	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Govindan	NULL
,	NULL
M.	NULL
V.	NULL
Expression	NULL
of	NULL
human	NULL
glucocorticoid	NULL
receptor	NULL
gene	NULL
and	NULL
interaction	NULL
of	NULL
nuclear	NULL
proteins	NULL
with	NULL
the	NULL
transcriptional	NULL
control	NULL
element	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
277	NULL
:	NULL
18662-18671	NULL
,	NULL
1996	NULL
.	NULL

Castren	NULL
,	NULL
M.	NULL
,	NULL
Trapp	NULL
,	NULL
T.	NULL
,	NULL
Berninger	NULL
,	NULL
B.	NULL
,	NULL
Castren	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Holsboer	NULL
,	NULL
F.	NULL
Transcriptional	NULL
induction	NULL
of	NULL
rat	NULL
mineralocorticoid	NULL
receptor	NULL
gene	NULL
in	NULL
neurones	NULL
by	NULL
corticosteroids	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

,	NULL
14	NULL
:	NULL
285-293	NULL
,	NULL
1995	NULL
.	NULL

Dai	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Maiorino	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Gkonos	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
Burnstein	NULL
,	NULL
K.	NULL
L.	NULL
Androgenic	NULL
up-regulation	NULL
of	NULL
androgen	NULL
receptor	NULL
cDNA	NULL
expression	NULL
in	NULL
androgen-independent	NULL
prostate	NULL
cancer	NULL
cells	NULL
.	NULL

Steroids	NULL
,	NULL
67	NULL
:	NULL
531-539	NULL
,	NULL
1996	NULL
.	NULL

Ledai	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Burnstein	NULL
,	NULL
K.	NULL
L.	NULL
Two	NULL
androgen	NULL
response	NULL
elements	NULL
in	NULL
the	NULL
androgen	NULL
receptor	NULL
coding	NULL
region	NULL
are	NULL
required	NULL
for	NULL
cell-specific	NULL
up-regulation	NULL
of	NULL
receptor	NULL
messenger	NULL
RNA	NULL
.	NULL

Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

,	NULL
10	NULL
:	NULL
1582-1594	NULL
,	NULL
1996	NULL
.	NULL

Geley	NULL
,	NULL
S.	NULL
,	NULL
Hartmann	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
Hala	NULL
,	NULL
M.	NULL
,	NULL
Strasser-Wozak	NULL
,	NULL
E.	NULL
M.	NULL
C.	NULL
,	NULL
Kapelari	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Kofler	NULL
,	NULL
R.	NULL
Resistance	NULL
to	NULL
glucocorticoid-induced	NULL
apoptosis	NULL
in	NULL
human	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
CEM-C1	NULL
cells	NULL
is	NULL
due	NULL
to	NULL
insufficient	NULL
glucocorticoid	NULL
receptor	NULL
expression	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
56	NULL
:	NULL
5033-5038	NULL
,	NULL
1996.	NULL
.	NULL

Thompson	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
Smith	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Bourgeois	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Harmon	NULL
,	NULL
J.	NULL
M.	NULL
Glucocorticoid	NULL
receptors	NULL
in	NULL
human	NULL
leukemias	NULL
and	NULL
related	NULL
diseases	NULL
.	NULL

Klin	NULL
.	NULL

Wochenschr	NULL
.	NULL

,	NULL
63	NULL
:	NULL
689-698	NULL
,	NULL
1985	NULL
.	NULL

Gasson	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
and	NULL
Bourgeois	NULL
,	NULL
S.	NULL
A	NULL
new	NULL
determinant	NULL
of	NULL
glucocorticoid	NULL
sensitivity	NULL
in	NULL
lymphoid	NULL
cell	NULL
lines	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
96	NULL
:	NULL
409-415	NULL
,	NULL
1983	NULL
.	NULL

Howe	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Skryabin	NULL
,	NULL
B.	NULL
V.	NULL
,	NULL
Belcher	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Zerillo	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Schmauss	NULL
,	NULL
C.	NULL
The	NULL
responsiveness	NULL
of	NULL
a	NULL
tetracycline-sensitive	NULL
expression	NULL
system	NULL
differs	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
270	NULL
:	NULL
14168-14174	NULL
,	NULL
1995	NULL
.	NULL

Compton	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Cidlowski	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

Rapid	NULL
in	NULL
vivo	NULL
effects	NULL
of	NULL
glucocorticoids	NULL
on	NULL
the	NULL
integrity	NULL
of	NULL
rat	NULL
lymphocyte	NULL
genomic	NULL
deoxyribonucleic	NULL
acid	NULL
.	NULL

Endocrinology	NULL
,	NULL
118	NULL
:	NULL
38-45	NULL
,	NULL
1986	NULL
.	NULL

Bansal	NULL
,	NULL
N.	NULL
,	NULL
Houle	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Melnykovych	NULL
,	NULL
G.	NULL
Apoptosis	NULL
:	NULL
mode	NULL
of	NULL
cell	NULL
death	NULL
induced	NULL
in	NULL
T-cell	NULL
leukemia	NULL
lines	NULL
by	NULL
dexamethasone	NULL
and	NULL
other	NULL
agents	NULL
.	NULL

FASEB	NULL
J.	NULL
,	NULL
5	NULL
:	NULL
211-216	NULL
,	NULL
1991	NULL
.	NULL

Wyllie	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
Morris	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Smith	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Dunlop	NULL
,	NULL
D.	NULL
Chromatin	NULL
cleavage	NULL
in	NULL
apoptosis	NULL
:	NULL
association	NULL
with	NULL
condensed	NULL
chromatin	NULL
morphology	NULL
and	NULL
dependence	NULL
on	NULL
macromolecular	NULL
synthesis	NULL
.	NULL

J	NULL
.	NULL

Pathol	NULL
.	NULL

,	NULL
142	NULL
;	NULL
67-77	NULL
,	NULL
1984	NULL
.	NULL

Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1999	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

AAGR	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
Cancer	NULL
Research	NULL
The	NULL
Journal	NULL
of	NULL
Cancer	NULL
Research	NULL
(	NULL
1916-1930	NULL
)	NULL
|	NULL
The	NULL
American	NULL
Journal	NULL
of	NULL
Cancer	NULL
(	NULL
1931-1940	NULL
)	NULL
Glucocorticoid-induced	NULL
Cell	NULL
Death	NULL
Requires	NULL
Autoinduction	NULL
of	NULL
Glucocorticoid	NULL
Receptor	NULL
Expression	NULL
in	NULL
Human	NULL
Leukemic	NULL
T	NULL
Cells	NULL
Jyoti	NULL
Ramdas	NULL
,	NULL
Wei	NULL
Liu	NULL
and	NULL
Jeffrey	NULL
M.	NULL
Harmon	NULL
Cancer	NULL
Res	NULL
378-1385	NULL
.	NULL

Updated	NULL
version	NULL
Access	NULL
the	NULL
most	NULL
recent	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//cancerres.aacrjournals.org/content/59/6/1	NULL
378	NULL
Cited	NULL
articles	NULL
Citing	NULL
articles	NULL
This	NULL
article	NULL
cites	NULL
49	NULL
articles	NULL
,	NULL
20	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//cancerres.aacrjournals.org/content/59/6/1	NULL
378	NULL
.full	NULL
#	NULL
ref-list-1	NULL
This	NULL
article	NULL
has	NULL
been	NULL
cited	NULL
by	NULL
14	NULL
HighWire-hosted	NULL
articles	NULL
.	NULL

Access	NULL
the	NULL
articles	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//cancerres.aacrjournals.org/content/59/6/1	NULL
378	NULL
.full	NULL
#	NULL
related-urls	NULL
E-mail	NULL
alerts	NULL
Reprints	NULL
and	NULL
Subscriptions	NULL
Permissions	NULL
Sign	NULL
up	NULL
to	NULL
receive	NULL
free	NULL
email-alerts	NULL
related	NULL
to	NULL
this	NULL
article	NULL
or	NULL
journal	NULL
.	NULL

To	NULL
order	NULL
reprints	NULL
of	NULL
this	NULL
article	NULL
or	NULL
to	NULL
subscribe	NULL
to	NULL
the	NULL
journal	NULL
,	NULL
contact	NULL
the	NULL
AACR	NULL
Publications	NULL
Department	NULL
at	NULL
pubs	NULL
@	NULL
aacr.org	NULL
.	NULL

To	NULL
request	NULL
permission	NULL
to	NULL
re-use	NULL
all	NULL
or	NULL
part	NULL
of	NULL
this	NULL
article	NULL
,	NULL
use	NULL
this	NULL
link	NULL
http	NULL
:	NULL
//cancerres.aacrjournals.org/content/59/6/1	NULL
378	NULL
.	NULL

Click	NULL
on	NULL
``	NULL
Request	NULL
Permissions	NULL
``	NULL
which	NULL
will	NULL
take	NULL
you	NULL
to	NULL
the	NULL
Copyright	NULL
Clearance	NULL
Center	NULL
's	NULL
(	NULL
CCC	NULL
)	NULL
Rightslink	NULL
site	NULL
.	NULL

Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1999	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

